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Abstract: Computer models allow the mechanistically detailed study of 
tumour proliferation and its dependency on nutrients. However, the 
computational study of large vascular tumours requires detailed 
information on the 3-dimensional vessel network and rather high 
computation times due to complex geometries. This study puts forward the 
idea of partitioning vascularised tissue into connected avascular 
elements that can exchange cells and nutrients between each other. Our 
method is able to rapidly calculate the evolution of proliferating as 
well as dead and quiescent cells, and hence a proliferative index, from a 
given amount and distribution of vascularisation of arbitrary complexity. 
Applying our model, we found that a heterogeneous vessel distribution 
provoked a higher proliferative index, suggesting increased malignancy, 
and increased the amount of dead cells compared to a more static tumour 
environment when a homogenous vessel distribution was assumed. We 
subsequently demonstrated that under certain amounts of vascularisation, 
cell proliferation may even increase when vessel density decreases, 
followed by a subsequent decrease of proliferation. This effect was due 
to a trade-off between an increase in compensatory proliferation for 
replacing dead cells and a decrease of cell population due to lack of 
oxygen supply in lowly vascularised tumours. Findings were illustrated by 
a mouse model of ectopic colorectal cancer xenografts. Our presented 
approach can be in the future applied to study the effect of cytostatic, 
cytotoxic and anti-angiogenic chemotherapy and is ideally suited for 
translational systems biology, where rapid interaction between theory and 
experiment is essential. 
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Dear Prof. Wolpert, 
 
We would like to thank the reviewers for their positive input and are happy to provide the 
revised manuscript following the addressing of their comments. Due to the pathology 
assessment required by Reviewer 2, we have now included the board-certified pathologists 
Prof. John J Callanan as co-author. 
 
On behalf of the authors, I am looking forward to your kind response 
 
With kind regards 
 
Heinrich Huber 
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1. Cover Letter
Prof. Dr. Lewis Wolpert 
Co-Editor-in-Chief,  
Journal of Theoretical Biology 
 
Leuven, Thursday, February 11, 2016 
 
RE: Revision, Besenhard et al., Modelling tumour cell proliferation … 
 
Dear Prof. Wolpert, 
We are grateful to the editor for granting us the possibility of resubmission and reviewers for 
their very constructive feedback. Based on their comments, we now provide a thoroughly 
reworked version of our manuscript and we are confident that we have addressed the reviewers’ 
comments in full and extensive detail. Beside the increased clarity of presentation our 
resubmission now includes the following highlights: 
- We refocused the aim of the study away from tumour growth to tumour cell proliferation 
as a means to assess the malignancy of a tumour tissue. This allowed us to better link our model 
to clinical studies that investigate proliferative indices (KI67 staining). We have therefore 
thoroughly reworked the entire manuscript to reflect this aim. To address the comments of both 
reviewers, we further better describe our modelling strategy that was focussed on integrating 
biophysical properties of tumour proliferation and nutrient perfusion, rather than on providing 
a mere fitting exercise with a reduced model. In line with this strategy, we are aiming to provide 
a novel framework that can be extended in future and whose modelling philosophy is in line 
with the one of the well cited study of Patel (J. Theor. Biol. 2001, PMID: 11735284) 
- As required by both reviewers, we perform a more detailed investigation of the influence 
of heterogeneous and homogenous tissues, and of differently perfused tumours, on tumour cell 
growth. We better highlight the biological consequences of our findings by relating cell 
proliferation to tumour malignancy. We discuss particularities of our findings that relate AVE 
and nutrient distributions to increased compensatory proliferation to replace dead cells in 
heterogeneous tissues (Fig. 3E-H). We further provide evidences for a trade-off between 
compensatory proliferation and oxygen perfusion for larger AVEs that lead to amounts of vessel 
densities where proliferation and dead cells showed a local maximum (Fig 5A).  
1. Cover Letter
- As required by reviewer 1, we now provide further information on absolute cell numbers 
for each population, oxygen, glucose and lactate profiles and discuss it in the context of 
experimental data (Fig 5BCD). 
- We now give a detailed description of the biophysical properties of Equation 4-7 and 
discuss the underlying biological and biophysical assumptions such they can be worked on 
better by the modelling community. As required by Reviewer 2, we further describe the 
numerical procedure in full detail that was used to solve the coupled equation system 1-9.  
- We provide an extended sensitivity analysis of assumed model parameters and assess 
how their alterations changes tumour cell amounts, both relative to each other and absolute 
changes (Figure 4 and Supplementary Figure 2). We furthermore better explain parameters that 
had to be introduced and better explain their biological significance in the methods section. We 
provide a proof of the stability of the numerical procedure with respect to granulation of tissue 
decomposition into AVEs (Fig 4C) and initial conditions (Supplementary Figure 3) 
In conclusion, we feel that the study has significantly improved and that the reworked version 
is of interest for the readers of the Journal of Theoretical Biology.  
 
We are looking forward to your kind response 
 
Yours sincerely, 
 
Prof. Dipl-Ing. Dr. Heinrich J. Huber, Associate Professor 
Cardiovascular Systems Biology, Department of Cardiovascular Sciences 
KU Leuven, Leuven, Belgium, Tel + 32 1637 2099 / +32 476 50 21 62 
 
Reviewers' comments: 
 
Reviewer #1:  
The authors have included most of the comments in the revised manuscript, however, there 
are still several (biologically) unjustified assumptions. I would strongly recommend that the 
authors point out the model assumptions and limitations at the end of discussion section of the 
manuscript. 
Authors’ response: We agree with the reviewer and hence have included the limitations of the 
model more prominently in a summary paragraph of the discussion. We thereby also again 
highlight that the model predicts proliferative indices and, as the necrotic core is neglected, 
was not designed to calculate absolute tumour size. In line with the comments of the other 
reviewer, we further emphasised that the model is seen predominantly as a tool to identify 
potential qualitative effects that are dependent on the biological context (page 16 5-25 in 
version with markups). 
Reviewer #2:  
The authors have made a considerable effort to improve their manuscript. While I still have 
issues with the predictive power of their model, their "model philosophy", and a few other 
details, I am inclined to leave it to the JTB readers to decide how convincing the manuscript 
is. However, I would ask the authors to make a few more changes before they resubmit the 
manuscript:  
In contrast to what the conclusion states, the model is not "scale free" as it contains 
parameters that together set the time and length scales (diffusion constants, consumption 
rates). I would drop this sentence. 
Authors’ response: We agree with the reviewer that the used constants define time and length 
dimensions and dropped the term (page 15 11-13 in version with markups). 
Tumours will often contain non-cancer cells (normal tissue cells, lymphocytes) which can 
also proliferate. A pathologist can however distinguish cancer- and non-cancer cells. Could 
the authors estimate how large was the proportion of non-cancer cells in their Ki67-stained 
samples? 
Authors’ response: We followed the reviewer’s suggestion and have assessed the amount of 
cancer cells in the KI67 staining by a board-certified pathologist (Prof John J Callanan). The 
pathologist confirmed that the rims of the tumour (outside the necrotic core and the adipose 
tissue rim) that were used for our KI67 analysis in Fig 7 are almost exclusively (>95%) 
populated with tumour cells at both day 8 and day 18, and cells with a morphology consistent 
with infiltrating cells are not discernible.  
We added the above analysis into the methods text (page 30/25-page 31/4) and included Prof 
Callanan as a co-author. 
Given the supposed realism of the model compared to spheroids, lattice models etc., it is 
slightly disappointing the model predicted only one number (% increase in proliferation) 
which agreed with the experiment only qualitatively. Could the authors make further 
*2. Response to Reviews (for Revision)
quantitative prediction which could be subsequently tested (perhaps by others)? This should 
not be too difficult given the confidence the authors have in their model. 
Authors’ response: We indeed made some quantitative predictions already in Fig 5 of the 
previously presented manuscript. Thereby, we have projected how the absolute 
concentrations of oxygen, glucose and lactate would change when vessel density decreases. 
We now better highlight the predictive nature of these calculations in the discussion (page 
14/6-12). We apologise for the previous shortcoming. 
Besides this, we would like to refrain from going into a too quantitative level. While the 
shown experimental data indicate that the assumptions underlying the model seem plausible, 
making quantitative predictions would spuriously suggest that our model can control all the 
parameters. We never made such a claim. Indeed, we doubt that all parameters that 
experimentally influence tumour proliferation in xenograft models are sufficiently known. 
Indeed, even using the same cancer cell xenografts in the same type of monogenetic rodents, 
may often lead to varying results in tumour proliferation.  
Therefore, as we have stated before, we see our model predominantly as a tool to identify and 
propose potential qualitative effects using parameters that can be controlled and that have 
been shown to be decisive for tumour proliferation. Such an example is the identified trade-off 
between an increase in compensatory proliferation for replacing dead cells and a decrease of 
cell population due to lack of oxygen supply in lowly vascularised tumours.  
We now highlight these restrictions at the end of the discussions (page 16 5-17). 
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Abstract: 1 
Computer models allow the mechanistically detailed study of tumour proliferation and its 2 
dependency on nutrients. However, the computational study of large vascular tumours 3 
requires detailed information on the 3-dimensional vessel network and rather high 4 
computation times due to complex geometries. This study puts forward the idea of 5 
partitioning vascularised tissue into connected avascular elements that can exchange cells and 6 
nutrients between each other. Our method is able to rapidly calculate the evolution of 7 
proliferating as well as dead and quiescent cells, and hence a proliferative index, from a given 8 
amount and distribution of vascularisation of arbitrary complexity. Applying our model, we 9 
found that a heterogeneous vessel distribution provoked a higher proliferative index, 10 
suggesting increased malignancy, and increased the amount of dead cells compared to a more 11 
static tumour environment when a homogenous vessel distribution was assumed. We 12 
subsequently demonstrated that under certain amounts of vascularisation, cell proliferation 13 
may even increase when vessel density decreases, followed by a subsequent decrease of 14 
proliferation. This effect was due to a trade-off between an increase in compensatory 15 
proliferation for replacing dead cells and a decrease of cell population due to lack of oxygen 16 
supply in lowly vascularised tumours. Findings were illustrated by an ectopic colorectal 17 
cancer mouse xenograft model. Our presented approach can be in the future applied to study 18 
the effect of cytostatic, cytotoxic and anti-angiogenic chemotherapy and is ideally suited for 19 
translational systems biology, where rapid interaction between theory and experiment is 20 
essential. 21 
 22 
  23 
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Introduction 1 
Vascularisation of tumours is essential for their progression and, therefore, several 2 
therapeutic strategies seek to target tumour vessels [1-3]. As a consequence, studying how the 3 
structure and amount of vessel penetration give rise to differing tumour proliferation patterns 4 
is of theoretical [4, 5], diagnostic [6, 7] and therapeutic interest [8, 9]. For such studies, 5 
mathematical and computational approaches are often applied [7, 10-14]. However, most of 6 
the existing models confine themselves to the study of avascular tumour proliferation. In turn, 7 
when models consider the detailed impact of the vessel network and the resulting supply of 8 
nutrients and waste disposal, they become mathematically complex, require high 9 
computational resources and are challenged by the incorporation of complex experimental 10 
data. Hence, such models are often impractical for systems biology, where a rapid cycle of 11 
theoretical predictions and experimental findings is required to obtain new biological insight 12 
[15, 16]. 13 
A technically simple and elegant method to study the interaction of cells and their vascular 14 
environment are cellular automata [17, 18], which are often combined with differential 15 
equation approaches. As such, Patel and colleagues [19] implemented a numerically fast, 16 
partial differential equation-based approach to calculate the spatiotemporal distribution of 17 
nutrients such as oxygen, glucose and disposal of waste (lactate) dependent on the vascular 18 
supply. This approach was combined with a 2-dimensional cellular automata model to study 19 
the distribution of proliferating, quiescent and dead tumour cells and their dependence upon 20 
nutrient supply via blood vessels. However, the benefit of simplicity came at the cost of 21 
disregarding information about the vascular structure, which would require a computationally 22 
extensive 3-dimensional cellular automata approach such as the one presented by Welter [13, 23 
14].  24 
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The aim of our study was to construct a model that includes first principle biophysical 1 
constraints on cellular migration, nutrient consumption, cell proliferation and cell death. We 2 
therefore built upon the ideas of Patel [19] and the work of the Galinsky group [11, 12]. 3 
Instead of taking into account extended complex vessel structure of an entire tumour, 4 
however, we assumed the existence and interplay of small avascular volume elements 5 
(AVEs) that make-up the tumour. Amount of vascularisation and its grade of heterogeneity 6 
can then be taken into account by different distributions of AVEs with different sizes. The 7 
AVE size distribution can then be used to calculate the number of proliferating, quiescent and 8 
dead cells in the tumour. We subsequently used the model to identify, and mechanistically 9 
explore, diverse hypotheses that relate vessel density and distribution to amount of tumour 10 
cell proliferation. We finally experimentally illustrate the presence of these novel findings by 11 
a de novo mouse xenograft model.  12 
 13 
14 
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Results 1 
A model to study vascularised tumours via decomposition into avascular elements 2 
We pursued a pragmatic approach for studying vascular tumour growth proliferation that is 3 
suitable for rapid hypothesis testing. We assumed a certain vascular tumour tissue which we 4 
decomposed into avascular elements (AVEs; Fig 1A).  We modelled that these AVEs 5 
exchange nutrients such as glucose, oxygen, and lactate (waste), together with cells via 6 
adjacent AVEs not separated by vessels (Fig. 1B). We reasoned that the relative AVE size 7 
distribution contains sufficient information to characterise the density and heterogeneity of 8 
tumour vascularisation (Fig 1C, having 10 different AVE sizes). For mathematical and 9 
computational simplicity, AVE’s were assumed as half cylindrical volumes with height 10 
equalling their diameter and a vessel at its centre (Fig 1D). Using this decomposition, we 11 
have transformed the problem of vascular tumour growth proliferation to the interplay of 12 
multiple AVE of a simple geometry, allowing us to reuse modelling methods, previously 13 
applied to study avascular cell proliferation [10, 20, 21]. Following these approaches, we 14 
studied the distribution of proliferating (P), quiescent (Q) and dead (D) cells within each 15 
AVE. We were interested in the relative composition of these cells within a given tissue 16 
rather than studying absolute tumour size. This was due to the fact that we regard a high 17 
proliferative index (the amount of proliferating cells per given tissue) as a means of tumour 18 
aggressiveness, leading to metastasis and relating to a worse prognosis [22-24]. We 19 
considered changes in each tumour cell type by transition rates. These transition rates were 20 
made dependent on oxygen, glucose and lactate concentrations and amount of available space 21 
for cell proliferation (Fig 2AB, Supplementary Figure 1AB, Table 3 and methods). Exchange 22 
between AVE’s was integrated by allowing a net flow of nutrients, waste and cells between 23 
AVE’s of different size, accounting for inter AVE gradients. This exchange is indicated by 24 
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the arrows in Fig 1B. Given that, in turn, this net flow was dependent on the actual nutrient 1 
and tumour cell concentrations of all AVEs, an iterative procedure was pursued to solve the 2 
equations. The used workflow is shown in Fig 2C and described in detail in the method 3 
section. The entire procedure was repeated for each tissue with a given vasculature. 4 
 5 
Calculation of an exemplary AVE size distribution from a virtual tissue as model input 6 
The relative AVE size distribution is the model’s starting point. Such AVE size distribution 7 
can be obtained from 2D and 3D images of entire tissues by any classical tiling approach [18, 8 
25, 26]. For our subsequent calculations, we however opted for a simpler procedure. The 9 
detailed procedure is described in the methods and was used for the entire calculations. We 10 
thereby generated an artificial 2D tissue. In this tissue, we distributed points that represent 11 
vessel, assuming inter vessel distances (IVD) that were taken from histology of colorectal 12 
carcinomas [27]. We subsequently used an algorithm to calculate the distance for each point 13 
of this artificial tissue to the nearest vessel, giving us a histogram for AVE sizes. We 14 
specifically assumed an average inter vessel distance of 75 M, but with different 15 
heterogeneity in vascular structure (Fig 3AB). In the remainder of the manuscript we will 16 
refer to them as homogeneous and heterogeneous vasculature (Fig 3C, red and black bars).  17 
 18 
The model predicts increased cell proliferation and death upon higher vessel 19 
heterogeneity 20 
Having determined a distribution of AVE sizes that represent a homogenously and 21 
heterogeneously vascularised tissue with the same average IVD (Fig 3C), we then 22 
investigated the effect of the different amount of vascularisation on the distribution of 23 
proliferating, quiescent and dead cells. We found that, while a homogenous tissue leads to 24 
very little proliferation and only limited cell death, a heterogeneous distribution led to 12% 25 
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cell death and 10% proliferating cells (Fig 3D). To investigate this further, we looked at the 1 
distribution of P, Q, and D cells in AVEs of different types. In the homogenous tissue, we 2 
observed some cell death in the larger AVEs 6-10 (Fig 3E), but this effect was greatly 3 
diminished once weighting over the volume distributions for AVES of the entire tissue (Fig 4 
3F; bars equal to 100%). In contrast, looking at AVEs of a heterogeneous tissue, we found 5 
markedly more proliferation in the smallest AVE and more cell death in the larger ones (Fig 6 
3G), such that the effect of proliferation and death was preserved when the contribution of 7 
each AVEs to the entire tissue was assessed (Fig 3H). Moreover, a small effect of 8 
proliferative compensation, whereby dead cells are replaced by nascent cells was observed in 9 
larger AVEs (small black area in Fig 3G) and also contributed slightly to the overall higher 10 
rate of proliferating cells in a heterogeneous tissue (Fig 3H). We conclude that a higher 11 
heterogeneous tissue leads to spatial areas with high cell proliferation and high cell death as a 12 
consequence of having rather small and rather large AVEs. In contrast, a homogenous tissue 13 
led to a high amount of quiescent cells due to a modest distribution of AVE sizes causing no 14 
significant compensatory proliferation of dead cells (see illustration in Supplementary Figure 15 
1CD). 16 
 17 
Sensitivity analysis suggests stability of our model to AVE partition 18 
Due to the higher proliferation characteristics of the heterogeneous tissue, suggesting higher 19 
tumour aggressiveness, we focussed on this in the further analysis. As certain parameters had 20 
to be estimated in the model, we wanted to consider their influence on the cellular 21 
composition. We therefore increased or decreased each of these 12 parameter by 10% and 22 
calculated absolute changes in relative or absolute cell compositions (see Fig 4AB and 23 
Supplementary Figure 2AB, respectively). This sensitivity analysis revealed that vessel 24 
permeability ( ), oxygen consumption (   ) and the proliferation threshold for oxygen (co PT) 25 
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were fairly influential factors. In addition, the robustness of the model was tested by 1 
increasing the number of AVEs, therefore representing finer grained AVE size distribution. 2 
This yielded a slight decrease of absolute cell numbers compared to the unchanged model 3 
(Supplementary Fig 2C), but, otherwise, lead to almost the same cell compositions when the 4 
number of AVEs was increased (Fig. 4C).  5 
 6 
Model calculation for different IVDs suggests that cell proliferation may increase when 7 
vascularisation decreases  8 
We next investigated the change of cell composition for different vessel densities. We 9 
therefore repeated our calculation of the AVE distribution from a virtual tissue using the 10 
method described before (Fig 3AB) and using a different average IVD as basis. As expected, 11 
calculating the amount of proliferating, quiescent and dead cells, we found that that the 12 
amount of total cells decreased with decreased vessel density (increased IVD), suggesting 13 
that under a very low vessel density, the tumour cannot sustain a large number of cells (Fig 14 
5A). This decrease was matched by a decrease of quiescent cells. However, when analysing 15 
the amount of proliferating and dead cells, we found that their amounts were increasing with 16 
increasing IVD until a peak was reached around an average IVD~80, followed by a 17 
subsequent decrease at higher IVDs. Looking at the predicted oxygen and glucose levels (Fig 18 
5BC), this surprising results could be explained by a trade-off between two effects. Firstly, at 19 
low IVDs, tissue nutrient perfusion was high, and hence amount of cell death and 20 
compensatory proliferation was low. When tissue becomes less vascularised, cells started to 21 
die, while enough supply was available to allow for compensatory proliferation. At higher 22 
IVD, however, oxygen levels fell under the threshold that is necessary for cell proliferation 23 
(Fig 5B small dashed line), leading to decreased proliferation and contributing to a further 24 
decrease in overall cell numbers. However, oxygen levels remained high enough to sustain 25 
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cellular survival (Fig 5B, dotted line) and therefore cell death continued to decrease as 1 
consequence of the decrease in total amount of cells. Finally, cellular glucose levels dropped 2 
while lactate levels increased when the average IVD was increased (Fig 5CD). All entities, 3 
oxygen, glucose and lactate, eventually reached a constant value. This constant value was 4 
established since not only nutrient perfusion of the tissue, but also nutrient consumption (due 5 
to a lower amount of cells) decreased when IVD increased. We further note that the 6 
calculated oxygen and glucose levels were consistent with physiological values [28-30] and 7 
experimental data of 0.08 mM and 5.5 mM as determined by [31]. In addition, we remark that 8 
values of oxygen, glucose and lactate at low vessel densities are consistent with those for 9 
mild hyperglycaemia, acidosis and hypoxia which are likely conditions in less perfused 10 
regions of the outer tumour rim.  11 
 12 
We then investigated the amount of proliferation and cell death in regions close to the 13 
proliferation peak. We therefore selected two average IVD values, IVD = 64 and IVD= 85 14 
and re-used the method of Fig 3AB to calculate vessel distributions associated to each IVD. 15 
We then calculated the amount of proliferating and dead cells. We observed an increase in 16 
cell proliferation of 38% and cell death of 31% (Fig 5E) when the average IVD was increased 17 
from 64 to 85. Analysing the relative contribution from each AVE between both 18 
distributions, we found that the increased proliferation was observed mainly in the smallest 19 
AVE. In contrast, the amount of dead cells was found in medium and larger AVE, together 20 
with a small concomitant increase in compensatory proliferation (Fig 5FG). We note that the 21 
assumption of a 37% increase in the average IVD between IVD = 64 and IVD= 85 (which is 22 
around the published value of IVD =75) [27] will be useful in the subsequent experimental 23 
analysis. 24 
 25 
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Decrease of micro vessel density is linked to increased tumour proliferation in 1 
subcutaneous HCT116-luc2 tumour  2 
Our modelling results provided evidence that an increased proliferation can be present even 3 
under decreased vascularisation (i.e. increased IVD) within certain vascularisation regimes. 4 
We therefore were interested if we could illustrate this relation by an experimental case. To 5 
do so, we required a model system for rapid hypothesis testing where the same type of 6 
tumour was analyses under a different amount of vascularisation. We  hence used a mouse 7 
xenograft model established in our laboratory  [32] where human HCT116-luc2 colon cancer 8 
cell lines were subcutaneously (SubQ) implanted into Balb/c nude mice.  We sacrificed mice 9 
at day 8 (n = 2) and day 18 (n = 2) post-implantation and analysed tumours histologically in 10 
10 independent fields of the outer tumour rim from 2 mice at each time point.  11 
We first used IHC staining with PECAM1/CD31 antibody to determine the microvessel 12 
density (MVD) which is an experimental measure of the level of vascularisation and which 13 
has an inverse relationship to the IVD we used in the model. We observed a significant (p = 14 
0.006) decrease in MVD of about 27 % from 22.4 ± 2.4 (day 8) to 16.3 ± 2.0 (day 18) (Fig. 6 15 
A-C).  16 
The observed decrease in MVD in our SubQ model may be the result of increased 17 
biomechanical forces and vessel instability from day 8 to 18 as suggested by theoretical 18 
studies [33]. However, we were not interested in rigorously further pursuing this effect, but 19 
aimed to check the emergent consequence of this MVD decrease on the amount of 20 
proliferating and necrotic cells. We note that this decrease in MVD of 27% between day 8 21 
and day 18 translates to an increase of IVD of 37% such as the one from IVD=64 (day 8) to 22 
IVD=85 (day 18) as assumed by Fig 5. 23 
We therefore repeated the analysis on the same tumours using KI67 staining for proliferating 24 
cells and TUNEL staining of cells dead by apoptosis, which is the predominant type of cell 25 
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death in the outer rim region. Interestingly, despite decreased MVD, we identified a 1 
significant (p = 0.0006) increase in cell proliferation from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 2 
% (day 18) (Fig 6 D-F). This 44% increase in proliferation was a bit higher than model 3 
predictions of increased proliferation of 38% that was calculated from our model when IVD 4 
was increased from IVD=64 to IVD=85. Likewise, TUNEL apoptosis staining from ten 5 
independent fields of the same tumours revealed a non-significant (p = 0.098) increase of 6 
number of TUNEL-positive cells per field of view from 5.8 ± 0.7 (day 8) to 8.0 ± 0.8 (day 7 
18), reflecting an 38% increase that coincides with a model prediction of a 31% increase (Fig. 8 
6 G-I).  9 
10 
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Discussion 1 
In this study, we developed a method to investigate how complexity and amount of vessel 2 
structures is correlated with tumour cell proliferation and death within a tissue. The benefit of 3 
this approach lies in its easy integration of experimental data, numerical speed and in the fact 4 
that neither large scale geometric information nor sophisticated numerical calculations are 5 
needed, allowing for a rapid cycle between theoretical predictions and preclinical validations. 6 
The input to our approach are size distributions of avascular elements (AVE’s) that give 7 
abstract information about vessel density and grade of heterogeneity at certain time points of 8 
the tumour. We wish to highlight here that our approach is therefore independent of the way 9 
these distributions are calculated. Here, we generated an AVE size distribution by applying a 10 
simple tiling method using stochastic seeding of test points and investigated the distance to 11 
the nearest vessels. For this specific method we assumed vessel distribution along a simulated 12 
2D tissue. Hence, we did not take into account physiological branching structures, whereby 13 
larger vessels branch successively into smaller ones in a tree-like fashion to guarantee 14 
optimal nutrient support [34]. Therefore, any method to calculate AVE size distributions from 15 
realistic vascular tumours would require more sophisticated approaches in a 3D space [25, 16 
26] such as Voronoi tessellation [18]. Nevertheless, such a physiologically homogenous 17 
vessel branching would also be expected to have a lower dispersion of AVE volume sizes 18 
than a heterogeneous one [35], exactly such as in our approach.  19 
The developed model predicts that tumours with a heterogeneous vessel distribution exhibit  20 
higher proliferation and more cell death compared to tumours with equal vessel densities and 21 
a more homogeneous vessel distribution. This is due to a higher spread of the AVE size 22 
distribution for tissues with higher heterogeneity resulting in areas with a high nutrient 23 
supply, and thus greater proliferation, but also areas with low nutrient supply and cell death. 24 
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Our predictions are consistent with experimental findings from mouse mammary xenografts 1 
where tumour cell proliferation was mainly observed close to areas surrounded by vessels 2 
[36]. Because of their higher cell turnover (more cell death and consequent higher 3 
compensatory proliferation), tumours of heterogeneous tissues may thus have higher 4 
mutation rates, better genetic adaptation and higher aggressiveness. It is therefore tempting to 5 
speculate that by reducing heterogeneity as done by VEGF-inhibitors such as Avastin, 6 
mutational rates may be lowered in highly heterogeneously vascularised tumours and, hence, 7 
malignancy may be mitigated or tumours may be more amenable to standard treatments [37-8 
39]. 9 
 10 
Using the gold-standard HCT-116-SQ mouse xenograft, we have observed a decrease in 11 
MVD of tumours in the colorectal cancer model employed. While this result warrants a more 12 
rigorous investigation, a similar finding has been observed previously by Hemmerlein 2001 13 
et al [40]. It was, however, not our aim to investigate vascularisation kinetics during tumour 14 
growth or even compare our mouse model to others, as this would have required a larger 15 
scale investigation. For our approach this change in MVD was a convenient choice to study 16 
the effects of changed microvessel density on the cell proliferation in a tumour.  17 
 18 
Our modelling approach qualitatively reflected the trend of our mouse model that vessel 19 
density negatively correlates with tumour proliferation under some regimes of 20 
vascularisation. The effect was explained by a trade-off between increase in compensatory 21 
proliferation for replacing dead cells and a decrease of cell population due to lack of oxygen 22 
when nutrient perfusion gets low. Our combined model and experimental efforts therefore 23 
suggest that the apparently trivial relationship between increased vascularisation and 24 
proliferation does not necessarily hold for all situations. Consistent with our findings, Lee 25 
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and co-workers found an inverse correlation between microvessel density and numbers of 1 
apoptotic cells in mammary ductal carcinoma. They further reported an inconclusive 2 
relationship between microvessel density and proliferation [9], disputing the notion that 3 
vascularisation is intrinsically linked to higher proliferation in all vascularisation regimens. 4 
Besides these qualitative predictions, we predicted quantitative changes of oxygen, glucose 5 
and lactate during changes of the IVD which can be validated in follow-on experimental 6 
studies. Specifically, we note that our values of 50-150 nmol/cm
3
 oxygen (0.05-0.15 mM), 3-7 
4.5 mol/cm3 glucose (3-4.5 mM) and 1-2.4 mol/cm3 (1-2.4 mM) of lactate are in excellent 8 
agreement with physiological levels of glucose 2-5 mM and lactate (0.5-2.2 mM; [28]) in 9 
blood and with oxygen and glucose levels from Jiang et al [31] of 0.08 mM and 5.5 mM.  10 
 11 
 12 
   13 
The validity of our model is confined to studying the proliferation characteristics in the outer 14 
rim of the tumour. Specifically, we neglected the necrotic core which is the most decisive 15 
factor for tumour expansion. Taking into account the necrotic core would have resulted in 16 
discontinuous AVE size distribution with the necrotic core as one large AVE that is 17 
connected to several smaller ones. This would have violated our assumption that all AVEs 18 
are continuously distributed and connected with each other in an equal manner. Moreover, 19 
the high space demand in the tumour core would require us to take into considerations high 20 
biomechanical forces which would be at odds with our model of free nutrient diffusion and 21 
the simple convective-diffusive transport of cells (Equations 4-5). Therefore, instead on 22 
focussing on tumour expansion, we rather investigated the proliferative index of a given 23 
tissue. Indeed, the KI67 proliferative index is positively correlating with tumour grade, 24 
metastasis and worse prognosis in solid tumours [22-24], rendering the fact that cancer dead 25 
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is more related to the propensity of metastasis than with growth of the primary tumour [41, 1 
42]. Likewise, Vartian and Weidner observed that KI67 staining in the tumour cores of 2 
samples from patients with breast carcinomas was 45-fold greater than in adjacent tissue [7], 3 
demonstrating the relevance of this parameter for tumour progression 4 
 5 
Other models have been developed to study the effects of vascularisation using cellular 6 
automata [13, 19, 43, 44], stochastic differential equations [45] or multiphase model 7 
approaches [46, 47]. Even if they were experimentally validated, such models are often 8 
restricted to the study of tumour spheroids and not applied to the study of vascularised 9 
tumours [10, 21]. Indeed, approaches using cellular automata easily become computationally 10 
complex and cannot be applied for studying larger tumours. In contrast, our presented model 11 
is principally scale free, which means that tumours of different size can be studied with the 12 
same mathematical and numerical formalism for tumours of different sizes. As our tiling 13 
method for studying AVEs may require finer granularity for larger and more heavily 14 
vascularised tumours, restrictions in tumour size may only apply indirectly. Nevertheless, the 15 
computational effort of our algorithm scales with linear power in the number of different 16 
vascular elements N for the equations 1-3 and has only quadratic dependency on the amount 17 
in the exchange term equation 4-9, which for the current calculation consumed less than 10 % 18 
of calculation time. This may become prominent for higher values of numbers of AVEs. In 19 
contrast, Cellular Automata approaches scale with the cubic power of the number of grids 20 
used per tumour length. This together with the smaller numbers of AVEs compared to the 21 
amount of grids gives our approach an advantage over 2D and especially 3D Cellular 22 
Automata approaches with respect to numerical costs. 23 
 24 
 25 
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 1 
In conclusion, we provide here a pragmatic approach to tackle the complex problem of 2 
avascular tumour growth by decomposing it to small avascular elements, thereby allowing 3 
the use of existing reaction-diffusion models from the vast literature of modelling spheroid 4 
growth. We constructed a model that includes first principle biophysical constraintsIn 5 
conclusion, the model concededly has its limitations. Firstly, as the model cannot account for 6 
studying growth of the necrotic core, it cannot be used to assess the size of the tumour, but 7 
focuses rather on studying a proliferative index dependent on amount and type of 8 
vascularisation. Secondly, we modelled only tumour cells and not tumour stromal cells. 9 
Hence, the formalism shall be adapted when other regions than the proliferative tumour rim 10 
are modelled such as adjacent adipose tissue which would have other metabolic and 11 
proliferative rates. We further only provided a qualitative estimation of cell and nutrient 12 
exchange terms (Eq. 4 and 5) and this formalisms may be further improved once a theory of 13 
convection and diffusion of cells and nutrients is available. We finally mostly refrained from 14 
going into predictions on a too quantitative level. We rather used the model as a tool to assess 15 
potential relevant qualitative effects that arise during tumour proliferation as consequence of 16 
different amounts and different heterogeneity of vascularisation. Indeed, we are not entirely 17 
sure that all parameters to remodel a quantitative proliferative response are experimentally 18 
known and controlled, and hence only focussed on those experimental parameters that are 19 
currently widely accepted to control tumour proliferation.  and that may be refined by the 20 
biophysical community in further studies. We Despite these drawbacks, we provide here a 21 
pragmatic model that includes first principle biophysical constraints. With this concept, we 22 
were able to tackle the complex problem of vascular tumour proliferation by decomposing 23 
the tissue into avascular elements, allowing us to reuse concepts from modelling spheroids. 24 
We preferred this this first-principle, qualitative approach over a merely fitting exercise 25 
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where parameters are adapted to correct for the inevitable model abstractions of a highly 1 
simplified model. We demonstrated that this approach model concept can serve as a template 2 
for analysis of experimental tumour models and that it was even was possible to render 3 
quantitate trends of cell proliferation and cell death under altered vasculature. We present this 4 
approach to the readers of JTB for further elaboration by the biophysical community in 5 
follow on studies. In the future, our approach can be extended to integrate mechanisms of 6 
tumour vessel development [25, 26] or to include the effect of cytotoxic and cytostatic 7 
chemotherapy, which could be simply implemented by making the cell transition rates of Fig. 8 
2B dependent on drug action. Likewise, it would allow the study of anti-angiogenic drugs by 9 
modelling their impact on tumour vasculature and exploiting the model to assess changes in 10 
tumour cell composition. 11 
12 
 Vascular tumour models studied by avascular elements 
 18  
Methods 1 
Ethics statements 2 
All animal experiments were performed by licensed investigators in accordance with animal 3 
research guidelines (Department of Health and Children, Dublin, Ireland) and protocols were 4 
approved by the Animal Research Ethics Committee at University College Dublin, where the 5 
work was performed. Animals were housed in groups, maintained on a 12 hour light/dark 6 
cycle, with access to food and water ad libitum.  7 
Modelling vascularised tumours by decomposition into avascular elements 8 
A semi-phenomenological approach was chosen to account for the influence of the vascular 9 
system. Thereby, the vascular system was assumed to serve as source and drain for nutrient 10 
and waste and thereby affect tumour proliferation [11]. To facilitate calculation of nutrient 11 
supply and waste removal, the complex 3-dimensional vessel structures was replaced 12 
assuming the tissue to be composed of avascular elements (AVEs). An illustration of the 13 
concept is given in Fig. 1A-B. AVE volumes with the characteristic radius      and their 14 
relative fractions were estimated by the following procedure. AVEs were assumed to have a 15 
geometry that is simplified to half cylinders whose height equalled their diameter. A vessel 16 
with a constant radius was assumed to be located at the cylinder’s centre (Fig 1D). Due to this 17 
approximation cylindrical coordinates and periodic boundary condition (Table 5) could be 18 
used, allowing for a simplified (i.e., one dimensional) calculation of nutrient and cell profiles 19 
within the AVE volume. The relative fraction of AVEs of different sizes, (i.e., the AVE size 20 
distribution), represents the underlying vessel structure such as vessel density and regularity. 21 
The AVEs were assumed to be connected with each other to allow the exchange of cells, 22 
nutrients, and waste. Mathematically, this exchange was incorporated with the aid of the 23 
exchange source terms in the PDEs as described below. Boundary conditions according to 24 
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Table 4 were assumed to model transport of nutrients/waste out of/into blood vessels. The 1 
transport dynamics was made dependent on the concentration gradient at the vessel wall and 2 
its selective permeability as in [19]. Migration of cells between the vessel and the tumour was 3 
disregarded. 4 
 5 
Quantification of relative occurrence of avascular elements 6 
To obtain an AVE size distribution from intervessel distances (IVD), we created a 2D virtual 7 
tissue whereby we spotted virtual vessels with the given IVD (=75 µm) and with a vessel 8 
diameter (             m) that reflected previously published data (Fig. 3AB) [27]. To 9 
generate homogeneously and heterogeneously virtual tissues of the same vessel density, spots 10 
(representing the vessels) were equidistantly distributed for both tissue types. In the case of 11 
the heterogeneous tissue, twice as many spots were placed initially and half of them were 12 
removed arbitrarily to create an irregular pattern. In order to obtain the AVE size distribution 13 
that represents a tissue, 10 000 test points were randomly placed into the virtual tissues. 14 
Afterwards, distance distributions of these points from the two nearest vessels were 15 
determined (       ), and the characteristic length of an AVE was defined by         16 
                AVEs were binned into 10 equally spaced containers according their 17 
characteristic radii                                              ;         = 76 18 
m,         = 103 m for homogenous and         = 61 m,         = 204 m for 19 
heterogeneous tissue) leading to a histogram of relative occurrence   , hist      :=   20 
               .  21 
Finally, to account for the fact that randomly placed points have a greater likelihood to be 22 
counted by this procedure due to their larger area [48], the probability distribution of the 23 
recorded histogram       was weighted by the AVE cross section 24 
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                      with           
           
 . The relative occurrence of 1 
AVEs in the tissue         is plotted in Fig 3C, whereby homogenously and 2 
heterogeneously vessel distribution differed in the spread of the covered range of 3 
characteristic radii. From the characteristic radii, AVE volumes were created according to the 4 
formula of half cylinders with same height as diameter Voli =          
          
     5 
       . The volume distribution is hence characterised by those from the corresponding radii 6 
with an x-axis that scales with the third order of the radii.  7 
As mentioned above the vessel homogeneity in this paper denotes an average distribution of 8 
vessels in two dimensions, and not a physiologically observed 3-dimensional tree-based 9 
vessel structure. 10 
Dynamic equations of oxygen, glucose, waste and tumour cell types within AVEs 11 
To calculate the dynamics of nutrients, waste and tumour cells within a particular AVE, a 12 
framework as frequently applied to tumour spheroids was followed. Therefore, tumour 13 
proliferation profiles within each AVE were calculated by determining spatiotemporal 14 
profiles of different tumour cell types. Consistent with approaches in [49, 50] the number of 15 
proliferating (P), quiescent (Q) and dead (D) cells (as a collective term for all types of cell 16 
death) per volume unit was assumed. Their evolution was influenced and in turn influences 17 
the availability of glucose (g), oxygen (o) and waste (w, lactate within this work).  18 
Oxygen, glucose, and waste were assumed to penetrate via the vessels walls. While oxygen 19 
and glucose are consumed, waste is produced by proliferating or quiescent tumour cells (P, 20 
Q). The temporal (time t) and spatial (radius of the AVE r) evolution of their concentration co 21 
(r,t), cg (r,t) and cw (r,t) within each AVE is given by the following-reaction diffusion 22 
equations:  23 
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Equation 1 
In the partial differential equations (PDEs) in Equation 1 the first term on the right hand side 2 
describes the diffusion of oxygen, glucose and waste with respective diffusion constants 3 
  ,  ,  , assuming that these entities diffuse homogenously through the entire tissue. The 4 
entities   ,   ,    denote the source terms that account for change of oxygen, glucose or waste 5 
by their turnover (consumption or production) and the diffusive exchange of oxygen, glucose 6 
or waste among AVEs (via exchange terms as described later).  7 
The source terms of Eq. 1 were modelled by 8 
                         
                         
                        
 
 
Equation 2 
whereby oxygen and glucose were consumed by proliferating P (with rate per cell of     and 9 
   ,, respectively; Table 1) and quiescent cells Q (with rate per cell of     and    ; Table 1). 10 
Likewise,     and     were the rate of waste production by proliferating and quiescent cells, 11 
respectively. The terms         ,         ,         were denoted in this paper as AVE 12 
exchange source terms and account for the exchange between AVEs of different size as 13 
subsequently described.  14 
The spatiotemporal concentration of all cell types (P(r,t), Q(r,t), D(r,t)) was modelled by 15 
 16 
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Equation 3 
with c denoting the dependency of above parameters on oxygen, glucose and waste 1 
concentration as described below. As before, all cell types were modelled to diffuse within 2 
the extracellular matrix as given in the first term on the right hand side of each equation and 3 
characterised by the effective diffusion constants Dp, Dq and Dd. These diffusion constants 4 
were modelled to depend on the total cell density (        ) to account for diffusion 5 
impairment due to increased cell crowding following the approach of Gatenby [11, 12]. Here, 6 
the density-dependent effective diffusion coefficients were defined as           7 
                                   . We thereby set        
     
     
   8 
      to obtain a stable decaying function with cell density cd and used the constant 5 to 9 
have diffusion sufficiently blocked at maximum cell densities       (<1% of max). 10 
Further terms at the right hand side of Equation 3 characterise the transition of cells between 11 
of different types (P, Q, D) as illustrated in Fig. 3A. For these terms in Equation 3 the 12 
transition parameter   denotes the rate of cell birth,    the rate at which proliferating cells 13 
become quiescent,    the rate at which quiescent cells become proliferating,    the rate of 14 
quiescent cells dead and    accounts for the disintegration and removal of dead cells which 15 
was assumed to be                      . The factor 100 cm
-1
 was assumed to allow 16 
for a moderate dependency with AVE size (as      was given in cm for our calculations, 17 
therefore the exponential factor varied around 1 for a typical AVE). The factor Kr (Table 1) 18 
was assumed to reflect a half time of degradation of 1.5 h which was considered as the typical 19 
time for phagocyting dead cells.  ,   , and    are described below.   , was constant while 20 
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   was made dependent on the AVE size to account for slower removal rates and response 1 
times (e.g. due to macrophages clearing the cellular debris) in the case of bigger AVEs.  2 
 3 
Transition rates between tumour cells and their dependency on nutrients, waste and cell 4 
density 5 
According to a procedure as given in [49, 50], tumour cells of different kinds were assumed 6 
to change their state as given in Fig 2. The respective transition rates for cell proliferation   , 7 
for proliferating cells becoming quiescent    and for quiescent cells to die    were modelled 8 
to be dependent on the cell density, and the concentration of oxygen, glucose and waste. 9 
Three different types of thresholds for oxygen, glucose and waste levels were introduced to 10 
incorporate the combinatorial effect of different nutrient/waste concentrations (see Table 1) 11 
on cell transition. These were the survival thresholds (             , proliferation thresholds 12 
(                 and a threshold for optimal conditions (                     For the making the 13 
transition rates dependent on nutrient and waste distribution (i.e.,        and   ), three 14 
specific conditions, denoted here as limit conditions, were assumed as follows:  15 
 16 
Rates under condition of cell death: Whenever either oxygen or glucose supply was assumed 17 
to fall below (                 , or waste was to exceed (       ), the respective 18 
survival thresholds, proliferating cells were assumed to become quiescent and quiescent cells 19 
were assumed to die                  . The following rules for transition rates at 20 
the different thresholds apply: 21 
 22 
Rates at the proliferation threshold: Whenever oxygen and glucose were exceeding the 23 
respective proliferation thresholds (                   , and the waste level was 24 
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undergoing the latter (        ), quiescent cells were modelled to become proliferating 1 
       and the rate of cell death was assumed to be zero        . 2 
 3 
Rates at and above the threshold for optimal proliferation: When, at the same time, oxygen 4 
and glucose concentration were above and waste concentration below the threshold for 5 
optimal conditions (  ≥       ,   ≥       ,            ), proliferation was maximum and rates 6 
for cells becoming quiescent or dead were zero       ,          ).  7 
 8 
These limit conditions for cell transition rates are summarized in Table 2. Values for   , 9 
  ,   between these limit conditions were interpolated via steady, differentiable, and 10 
monotonous functions of these transition rates for the entire range of glucose, oxygen and 11 
waste concentration. Therefore, cosine and sine functions scaled to the descending and 12 
ascending quadrant were chosen to have everywhere differentiable function that reflect the 13 
monotonous dependency of transition rates on the concentrations of nutrients and lactates  14 
(Table 3). Supplementary Figure 1AB depict how    and    depend on oxygen and glucose.  15 
Furthermore, we assumed cell transition rates to be dependent on the cell density. Cell 16 
proliferation was only possible if the cell density    was below the maximum density 17 
           
              according to [12]. This value is in good agreement with those 18 
obtained for EMT6/Ro tumour spheroids (                        ; [51]). To avoid 19 
that continuous cell proliferation could lead to cell densities higher than maximum value 20 
       the transition rate    was made to decrease and    to increase with increasing cell 21 
densities (        ) as described in Table 4. Likewise, the factor in KQ in Table 4 was 22 
chosen to restrict the total amount of cells to         23 
Calculation of the AVE exchange source terms         24 
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AVE’s of different sizes were assumed to be connected to each other (and are not fully 1 
separated by the vessel network). Therefore, cells, nutrients and waste were assumed to 2 
exchange among AVE’s of different volumes. Consequently, disequilibrium in cells, 3 
nutrients and waste results in a net flow of the latter between adjacent AVEs. We assumed 4 
that all AVEs were connected equally with each other, according to their relative 5 
occurrence       . This net flow was introduced in Equation 2-3 and denoted as exchange 6 
source terms      .  7 
Within the following we describe how the exchange source terms for oxygen and for 8 
proliferating cells (         and         , respectively) were calculated at each iteration step, 9 
assuming above average nutrient, waste or cell concentrations to be known. Calculations of 10 
source term corrections for glucose             and waste (          and other cell types 11 
(                 follow the same scheme. These exchange terms were assumed to be 12 
spatially independent. Therefore, the        terms could be considered to be constant over the 13 
entire distance of exchange which is the sum of the characteristic length             of 14 
adjacent AVEs. 15 
We first determine transfer rates for dissolved species such as nutrients and waste between 16 
AVEi and AVEj. We note that this exemplary choice of two AVEs does not require any 17 
specific spatial arrangements or other constraints, besides being of different size.  18 
As example we calculated the oxygen exchange rate         which was assumed to be 19 
dependent on the gradient between the average concentrations in the AVE (               ) as 20 
              
               
               
    
Equation 4 
 21 
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Equation 4 describes diffusive transport which is based on a flux rate according to Fick’s law 1 
of diffusion. The law assumes particles to move through a virtual area perpendicular to the 2 
diffusion direction and, hence, this flux is inversely proportional to the area spanned by the 3 
radii of both AVEs ([52], Supplementary Text 1). 4 
 5 
In contrast to nutrients and waste where diffusion is quick and dominates the transfer, the 6 
calculation of cellular transfer rates such as proliferating cells (       ) has also to account for 7 
convective transport. This convection is driven by different cellular occupancies leading to 8 
differential space restrictions and consequent pressure equilibration between AVEs. This 9 
generates a diffusion independent convective net flow that is dependent on the difference of 10 
cell densities in each AVEs (       ), but independent of the actual cell type (i.e. not driven by 11 
entropy). Consequently, we combined the diffusion term, here shown for proliferating cells, 12 
with a convective term (on the right side of Eq. 5)  13 
             
             
             
    
    
     
 
               
             
    . 
Equation 5 
We note that this represents a net flux that is analogous to the one of a convection-diffusion 14 
equation [53]. Thereby, the factor (
    
     
) of the second, convective term was adjusted to 15 
render cell occupancies for all AVEs which were assumed to vary only within a reasonable 16 
range of 20% between the smallest (          ) and biggest (          ) AVE. We note that 17 
this term presents solely a heuristic expression for convective transport that is consistent with 18 
above biological assumptions as no current detailed theory of cell convection within tumours 19 
is available. 20 
Above transfer rates were subsequently used to calculate the temporal change (exemplified 21 
here for oxygen) in AVE   and   by weighting the exchange among AVEs according to their 22 
volumes to guarantee conservation of mass (i.e. cells or species) 23 
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Equation 6 
By solving Equation 6, the net flow rates (here for oxygen) between two AVEs during a time 1 
step t can be determined as: 2 
                 
                             
  
 , 
Equation 7 
whereby                                  denote the oxygen concentrations at the beginning and 3 
end of a time step. Then, to capture the oxygen exchange between all AVE’s during a time 4 
step, we define the matrix  5 
                    
                           
   
                             
  . 
Equation 8 
We further assumed that all AVEs are equally connected with each other. This assumption 6 
requires that AVE distributions are continuous (i.e. no single large AVE such a necrotic 7 
core). It further requires that the AVEs in any heterogeneous distribution would be rather 8 
statistically distributed within the tissue, while for homogenous distribution (having smaller 9 
differences of AVE sizes) the exchange term would have minor impact. 10 
Finally, the exchange source term of an AVE   (here for oxygen) was obtained by summing 11 
up the exchange with all AVE’s during a time step, weighted by the relative AVE 12 
occurrence           : 13 
                   
 
                  , Equation 9 
Solution and numerical procedure for calculating proliferating, quiescent and death 14 
cells considering inter-AVE exchange 15 
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The differential equations 1-3 that describe spatiotemporal cell distributions within the AVEs 1 
and the equations 4-9 that describe the exchange terms between AVEs form a self-consistent 2 
problem. This means that from spatial distributions of nutrients, waste and P, Q and D cells in 3 
each AVE (as calculated via Eq. 1-3), the AVE exchange terms have to be calculated 4 
according to Eq. 4-9. In turn, the exchange terms feed again into the differential equation 1-3, 5 
requiring the need for an iterative procedure.  6 
The iteration was performed for a small, but finite time interval (       ), for which we 7 
could assume the AVE exchange terms as constant. This assumption of constant AVE 8 
exchange terms allowed to decouple equation 1-3 from equation 4-9 in their time 9 
dependency, facilitating the numerical solution. The iteration at a certain time step was 10 
continued till AVE exchange terms converged. After convergence of AVE exchange terms, 11 
the iteration was started again for the successive time step of the same finite time 12 
interval,       . Therefore, AVE exchange terms can change for successive time steps, but 13 
remain constant during each time interval. The exchange source terms of the first iteration 14 
were initialised using the values of the previous time interval. The workflow of this nested 15 
iterative procedure was shown in fig. 2C. This procedure was repeated until cell densities of 16 
P, Q and D cells did not change (<< 0.1%) during subsequent time intervals. Usually this was 17 
reached after 400 time steps and was greatly independent of initial conditions (used for the 18 
first time interval; see supplementary Figure 3). 19 
We note that above time intervals have a specific biological interpretation within the 20 
framework of the described numerical procedure. The reason is that the procedure assumes 21 
that a certain vasculature is present and that cell compositions and their spatial distributions 22 
adapt over time starting from arbitrary initial conditions. After this adaption, time intervals 23 
refer to the speed of how cell compositions evolve in response to a change in vasculature (a 24 
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disequilibrium that is given between the actual and the optimal spatiotemporal cell 1 
composition). 2 
 3 
Finally, concentration for proliferating (P), quiescent (Q) and dead cells (D) for the entire 4 
tissue were obtained by weighting the P, Q, N numbers of each AVE by the relative 5 
occurrence of the AVE and multiplying by its volume, e.g.  P=          
      
       
. All 6 
calculations were performed using MATLAB R2014 (The Mathworks, UK) using the in-built 7 
PDE solver (PDEPE). Code is provided by the authors on request. 8 
 9 
Calculation of the change of tumour proliferation characteristics for increasing 10 
microvessel density 11 
For model calculations in Fig 3, a heterogeneous vessel distribution as in Fig 3C was used. 12 
AVE size distributions were then calculated using the virtual tissue method as described 13 
above using the IVD as input. The observed experimental decrease of the microvessel 14 
distance between day 8 and day 18 by 27% was reflected by an increase of IVD by 37% due 15 
to the inverse relationship between both (IVD ~  1/MVD; 100% / 137% = 0.73, i.e. 27 % 16 
decrease). IVD values were hence chosen as 64 µm to 85 µm for day 8 and day 18, 17 
respectively, to be centred around the experimental value of 75 µm [27].  18 
 19 
Xenograft model   20 
Xenograft models were established by subcutaneous injection of 2.5 x 10
6
 HCT116-luc2 cells 21 
into the flank of Balb/c nude mice (Charles River Laboratories, UK). Tumours were 22 
harvested at days 8 (n = 2) and 18 (n = 2) and fixed in 10 % buffered formalin for 24 hours 23 
before being processed and paraffin embedded.  24 
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Histologic Examination and Immunohistochemistry 1 
Paraffin-embedded, formalin-fixed tissue sections from mouse HCT116-luc2 subcutaneous 2 
tumours were stained with Hematoxylin and Eosin (H & E) and anti-luciferase stained in 3 
order to access percentage of tumour core necrosis. Anti-KI67 and anti-PECAM1/CD31 4 
staining procedures were carried out to determine tumour cell proliferation and microvessel 5 
density respectively. In brief, tumour sections were deparaffinized with xylene and 6 
rehydrated according to standard histologic procedures. For epitope retrieval, sections were 7 
boiled for 20 minutes in 10 mM citrate buffer, pH 6.0. Sections were rinsed in Tris buffered 8 
saline (TBS)-Tween and blocked in 5 % serum in TBS for 1 hour followed by incubation at 9 
room temperature for 1 hour with the following primary antibodies: rabbit anti-Ki-67 10 
(Millipore, Billerica, MA), dilution 1:100; goat anti-luciferase polyclonal antibody (pAb) 11 
(Promega, Fitchburg, WI), dilution 1:50; and goat anti-PECAM-1 (M-20) (Santa Cruz 12 
Biotechnology, Inc., Dallas, TX), dilution 1:100 in TBS containing 1% serum. Biotinylated 13 
goat anti-rabbit or horse anti-goat secondary antibodies (Vector Laboratories, Burlingame, 14 
CA), dilution 1:200 in TBS/ 1 % serum, were applied for 1 hour at room temperature 15 
followed by ABC complex (Vectastain ABC kit, Vector Laboratories) incubation for 30 16 
minutes. Positive signal was developed with diaminobenzidine (DAKO, Glostrup, Denmark) 17 
according to the manufacturer’s instructions. Sections were counterstained with hematoxylin 18 
to visualize nuclei. TUNEL staining was performed according to manufacturer’s 19 
recommendations using ApoptoTag Peroxidase In Situ Apoptosis Detection Kit (Millipore, 20 
Billerica, MA).  21 
For assessment of proliferation indices (percentage of KI-67-positive cells), fractions of 22 
labelled tumour cells were assessed in 10 microscopic high-power fields per section using 23 
x40 magnification and ImageJ software (National Institutes of Health, Bethesda, MD). While 24 
the rabbit anti-KI67 antibody implemented cross-reacts with human and mouse tissue,  25 
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histopathological analysis confirmed that the tumour rim area  (outside the necrotic core and 1 
the adipose tissue) used for KI67 analysis in Fig 7 were almost exclusively (>95%) populated 2 
with tumour cells at both day 8 and day 18, and cells with a morphology consistent with 3 
infiltrating cells are not discernible. 4 
Microvessel density based on criteria previously described [54] was assessed.  5 
To quantify percentage of tumour core necrosis, whole slides were first scanned on a Leica 6 
microsystems whole slide imaging platform (Leica Microsystems, Wetzlar, Germany) and 7 
then area of tumour core necrosis versus whole tumour area was calculated using ImageJ 8 
software (National Institutes of Health, Bethesda, MD). Alternatively, representative images 9 
of stained tissue slides were captured using a Nikon 2000s epi fluorescence microscope with 10 
a Hamamatsu Orca 285 camera (Micron-Optical, Wexford, Ireland).  11 
Data Analysis 12 
Data are presented as the mean ± standard error of the mean (SEM). Two-group comparison 13 
was made using unpaired t-test or Mann Whitney test (PRISM GraphPad Software In.c., La 14 
Jolla, CA). Significance was accepted at p < 0.05. 15 
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Figure Legends 1 
Figure 1: Schematic representation of the method for decomposing vascular tissue into 2 
avascular elements (AVEs) (A) A vascular tumour is decomposed into different AVEs. 3 
Here four elements of different sizes are illustrated by different colours. (B) These elements 4 
(depicted as rectangles for convenience and colour code relating to (A), indicating different 5 
element sizes) were considered to exchange nutrients, waste and cells via diffusion. The 6 
small arrows indicate the exchange among the elements. Every AVE was assumed to be 7 
connected to an AVE of a different size with a probability proportional to their relative 8 
occurrence (C). This AVE size distribution is characterised by a histogram, whereby AVE’s 9 
are binned according their size. The shape of the histogram is an indicator of the regularity of 10 
the vessel system. (D) AVE geometry was simplified via a half cylindrical shape with a 11 
vessel at the centre and with a height being equal to the diameter of the cylinder. These 12 
assumptions reduced the mathematical complexity of the PDE system. 13 
 14 
Figure 2: Implementation of transition rates and numerical procedure (A) Scheme 15 
depicting the dependency of the three transition rates        and    on oxygen (co), glucose 16 
(cg) and lactate (waste; cw) concentrations at three different conditions. Cell death conditions 17 
(left panel) occur when either oxygen or glucose is below or waste is above a specific 18 
threshold value (Suffix T). Change from quiescence to proliferating cells occurs when 19 
concentrations exceed the proliferation threshold (medium panel; Suffix PT). Optimum 20 
conditions (Suffix opt) are achieved when, at the same time, oxygen and glucose are above 21 
and waste is below a specific concentration threshold (right panel). Between these thresholds, 22 
transition rates were interpolated using sine and cosine scaled to the descending and 23 
ascending quadrant to reflect the monotonous dependency of these rates on nutrients and 24 
wastes. (B) Transitions between proliferating (P), quiescent (Q) and dead (D) tumour cells 25 
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are depicted. Above the proliferation threshold, tumour cells proliferate at rate    and 1 
quiescent cells become proliferating at rate   . Below the proliferation threshold, 2 
proliferating cells become quiescent at rate KQ. Below the survival threshold, quiescent cells 3 
died at rate    and were removed according to a removal rate   . (C) The iterative procedure 4 
to calculate the AVE exchange term is depicted. A nested procedure was used. The inner 5 
iteration was used to solve Eqs. 1-3 along with Eqs. 4-9 at a certain time step t during a time 6 
interval t until AVE source terms were stable. Use of the time interval t allowed to 7 
consider the AVE exchange terms constant with respect to time during this comparably small 8 
interval. This decoupled the Eqs. 1-3 from Eqs. 4-9 in their time dependence and facilitated 9 
the numerical solution. In the outer loop, iteration was performed over subsequent time steps 10 
to account for the time dependency of AVE exchange terms. As starting conditions for each 11 
time step, AVE exchange terms of the previous step were used. The outer integration was 12 
stopped until also convergence for P, Q and D cells was achieved. Finally, the average 13 
number of P, Q and D cells per volume for a specific vascularisation were extracted. 14 
Figure 3: Calculated distribution of proliferating, quiescent and dead cells, and cell 15 
density over time emerging from homogenous and heterogeneous vascularisation (A-B) 16 
The principle of determining the relative abundance of AVEs with a characteristic diameter 17 
RAVE and its application to homogenous and heterogeneous vascularity is given. A virtual 18 
2D tissue was assumed for homogenous (A) and heterogeneous (B) vasculature (red spots). 19 
The distance to the two nearest adjoining vessels         from randomly placed dots was 20 
calculated assigning the characteristic length RAVE = ½ abs(      ) (see magnified graph). 21 
Volumes were calculated according Fig 1D to reflect 3D avascular elements (AVE). (C) 22 
Histograms for AVE distributions using a homogenous (grey bar) or heterogeneous (black 23 
bar) vasculature from the same average vessel density were given as derived from this 24 
procedure. (D) Calculated distribution of proliferating, quiescent and dead cells for a 25 
Feldfunktion geändert
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homogenous and heterogeneous vasculature (left column) with the same average IVD of 75 1 
m from panel C. While under a homogenous vasculature (E; absolute numbers Q: 4.7 108, P: 2 
1.6 10
6
, D: 5.0 10
5
), the amount of proliferating cells was negligible, a higher amount of these 3 
cells, and therefore a higher cell turnover, was predicted with a heterogeneous distribution 4 
(absolute numbers Q: 3.0 10
8
, P: 5.1 10
7
, D: 3.7 10
7
. (E, G) relative distribution of P (black), 5 
Q (dark grey) and D cells (light grey) in each of the 10 AVEs for homogenous and 6 
heterogeneous tissue, respectively.  Larger AVEs numbers depict bigger AVEs as 7 
characterised by the Radius RAVE from Fig 3C. For the homogenous tissue (E), only quiescent 8 
cells were present in most of the AVEs, while only the two biggest AVEs showed some dead 9 
and proliferating cells. For the heterogeneous tissue (G), proliferating cells were most 10 
prominent in the best perfused, smallest AVE, while dead cells were prominent in larger 11 
AVEs. Notably, compensatory proliferation, whereby dead cells are replaced was noted in 12 
medium size AVEs (proliferating rate higher in AVE 5-8 than in AVE 3). (F, H) Volume 13 
weighted relative distribution of P, Q, D cells for the homogenous (F) and heterogeneous 14 
tissue (H) are given, giving the percentages of cells of each type and in each AVE relative to 15 
the entire tissue (100%).  16 
Figure 4: Sensitivity analysis of the model Parameters that were not obtained from 17 
literature were subjected to a local sensitivity analysis, whereby each parameter was varied 18 
independently by 10%. Parameters are described in Table 1. The heterogeneous distribution 19 
from Fig. 3 was used (average IVD of 75 m). (A-B) Values of P, Q and D cells were given 20 
relative to the tissue and absolute deviation of these relative percentages were calculate when 21 
a parameter was changed by +/- 10 % compared to the one obtained by the reference value of 22 
the parameter of Table 1. The vessel permeability was identified as the most influential 23 
parameter. Only parameters which changed the cell composition by more than 0.1% were 24 
shown. (C) Same as (AB) for the cell compositions when using a different number of AVEs. 25 
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 1 
Figure 5: Change of cell composition over different amount of vascularisation reveals a 2 
peak of proliferating and dead cells around and average IVD of 80 m (A) Cell numbers 3 
for P (black dashed line), Q (dark grey dotted line), and D (light grey solid line) cells were 4 
given for heterogeneous tissues with different average IVDs. While the average amount of 5 
cells per tissue steadily decreased due to lack of nutrient supply, the amount of proliferating 6 
cells reached a peak at about 80 m as the decreasing overall cell number at regimens 7 
between 50 and 80 m allowed for quiescent cells to re-enter a proliferating state. dead cells 8 
matched that trend of proliferating cells. (B-D) Amount of oxygen (B) and glucose (C) 9 
supply together with lactate (waste, D) concentration over different heterogeneous tissues 10 
with given average IVD. Survival threshold, proliferation thresholds and optimal 11 
concentrations for the respective entities are given by dotted, small dashed and large dashed 12 
lines. Notably, oxygen levels cross the optimum proliferation threshold at ~80 m, leading to 13 
a decrease of proliferation at tissues with higher average IVD (lower vessel density). (E) 14 
Comparison of proliferating and dead cells for tissues with average IVDs of 64 and 85 that 15 
are around the peak of proliferating and dead cells. We observed an increase of 38% and 16 
31%, respectively, despite a tissue with lower vessel density. The increase in the average IVD 17 
of 37% matched the decrease of microvessel distance in Fig 6B of 27% due to an inverse 18 
relation between both. (F, G) Volume weighted relative distribution of P, Q, D cells for a 19 
heterogeneous vessel distribution of Fig. 3C and average IVDs of 64 (F) and 85 (G) are 20 
given. The percentages of cells of each type in each AVE are given relative to the entire 21 
tissue (100%).  22 
 23 
Figure 6: Model can predict evolution of tumour cells caused by changes in vascular 24 
density Microvessel density (MVD), proliferation index and number of apoptotic cells were 25 
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detected using a HCT116-luc2 SQ tumour mouse xenograft model and harvesting tumours at 1 
day 8 and 18. (A-C)  Representative images of PECAM1/CD31 staining are given (A-B). 2 
Staining was analysed for two mice for each time point using 10 randomly chosen fields 3 
outside the necrotic core lead to a significant decrease (p = 0.0059) in MVD from Day 8 4 
(22.4 ± 2.4) to Day 18 (16.3 ± 2.2; C). This relative decrease of 27% was considered as equal 5 
to an increase of 37% in the average IVD in our model according to their inverse relation. (D-6 
F) Evolution of proliferating cells between day 8 and day 18. KI67 antibody was used for 7 
staining proliferating cells (D-E). A significant increase (p = 0.0006) of proliferation in day 8 
18 tumours was observed from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 % (day 18), as MVD 9 
decreased (F). This experimental increase in proliferating cells (44%) was matched by the 10 
model (38%). (G-I) Evolution of dead cells from day 8 to day 18 as MVD decreases. 11 
TUNEL-staining of representative fields outside the necrotic core (G-H) indicated non-12 
significant (p = 0.098) increase in number of apoptotic cells (used to compare with the dead 13 
cells from the model) from 5.8 ± 0.7 % (day 8) to 8.0 ± 0.8 (day 18). Increase in dead cells 14 
(38%) qualitatively matched model data (31%). For all staining data bars represent mean ± 15 
SEM (day 8 (n = 10 images per tumour, n = 2 animals), day 18 (n=10 images per tumour, n = 16 
2 animals), quantifications from 10 randomly chosen field of views per section outside the 17 
necrotic core for each of the two mice sacrificed at the indicated dates, scale bar = 25 μm, * - 18 
p < 0.05, ns – non-significant, Mann-Whitney test 19 
 20 
Supplementary Figure 1: Transition rates and cellular distributions 21 
(A-B) Transition rates between P and Q in dependence on glucose and oxygen concentration 22 
relative to their optimal values (cg opt and co opt).  (C, D) Spatial distribution of the different 23 
cell types for the homogenous and the heterogeneous distribution were re-generated by 24 
randomly assigning the AVEs to spatial locations for illustration purposes. Dots were 25 
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coloured according to the probability of P, Q, or D cells in the particular AVE. Islands of cell 1 
death in the heterogeneous vessel distribution in (D) indicate high accumulation of dead cells 2 
arising from large AVE elements that were insufficiently supplied by nutrients or affected by 3 
high waste accumulation. 4 
Supplementary Figure 2: Extended sensitivity analysis  5 
Each parameter was varied independently by +/-10%. Parameters are described in Table 1. 6 
The heterogeneous distribution from Fig. 3 was used (average IVD of 75 m). (A-B) 7 
Absolute changes of P, Q and D cells were calculated when a parameter was changed by +/- 8 
10 % and given relative to the cell composition obtained when using the reference value of 9 
the parameter of Table 1. The vessel permeability was identified as the most influential 10 
parameter (C) Same as (AB) for the cell compositions when using different numbers of 11 
AVEs. 12 
 13 
Supplementary Figure 3: Stability of our method (Fig. 2C) to initial conditions Different 14 
initial conditions were used for the heterogeneous tissue with AVE=75 of Fig 3 from the 15 
main text and temporal evolvement of P, Q and D cells and the total cell density was 16 
calculated (A-D, respectively). Convergence was achieved at about 100 time steps. For the 17 
interpretation of time steps, please refer to the methods section. 18 
19 
 Vascular tumour models studied by avascular elements 
 41  
Tables 1 
Table 1: List of constants used in the model Rates for nutrient consumption, waste 2 
production, diffusion of cells and nutrients, and concentration thresholds for nutrients and 3 
waste for determining cell proliferation and death, were given along with their references. 4 
Constant Description Value/ Source 
                      Oxygen consumption of proliferating cells     
    [51] 
     
                 Glucose consumption of proliferating cells             
  [31, 55] 
                      Waste production of proliferating cells  
   
        
 [31, 55] 
                      Oxygen consumption of quiescent cells  
  
        
 [31, 55] 
     
                 Glucose consumption of quiescent cells           
 [31, 55] 
                      Waste production of quiescent cells  
   
       
 [31, 55] 
            Metabolic rates of dead cells   (assumed) 
      
     Empty space P cell diffusion constant           [31] 
      
     Empty space Q cell diffusion constant        (assumed)  
      
     Empty space N cell diffusion constant 0 (assumed) 
      
     oxygen diffusion constant           [31] 
      
     glucose diffusion constant           [31] 
      
     waste diffusion constant           [31] 
           
   Survival threshold for oxygen  
 
          [31] 
              
   optimal oxygen concentration  
 
          [31] 
            
   Proliferation threshold for oxygen  
     
             
   
 
(assumed) 
        Survival threshold for glucose         
   [31] 
           optimal glucose concentration        
   [31] 
         Proliferation threshold for waste  
    
    
    
 
 (assumed) 
        Survival threshold for waste      
   [31] 
            optimal glucose waste    [31] 
         Proliferation threshold for glucose  
    
    
    
 
 (assumed) 
           Vessel permeability 18.5*Do (assumed) 
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         Maximal transition rate between Q and P cells 
      
 
 (assumed) 
         
Maximal transition rate between P and Q cells 
(if survival thresholds are not reached) 
      
 
 (assumed) 
   [   ] Rate of cell birth       [49] 
 
        Maximal removal rate of dead cells 
      
    
 (assumed) 
 1 
Table 2: Limiting conditions for cell transition rates: Transition rates for the amount of 2 
quiescent cells becoming proliferating  , the amount of proliferating cells becoming 3 
quiescent    and for the number of quiescent cells dead    were given when different 4 
nutrient and waste concentrations converged against specific thresholds. The conditions are 5 
explained using    as example. 6 
Situation Condition Transition 
Parameter 
Remark 
Approach 
optimum 
concen-
tration 
                 
                 
                  
 
if              
 
     
      
(= maximum 
value) 
     
Under optimal conditions (glucose and 
oxygen above optimum concentration 
and waste below) no proliferating cells 
become quiescent, and quiescent cells 
become proliferating with a constant 
rate 
Approach 
prolifer-
ation 
threshold 
                   
              
              
 
if              
 
 
    
 
 
 
      
     
     
If conditions approach the proliferation 
threshold the transition rate of 
proliferating to quiescent cells becomes 
a constant 
Approach 
survival 
threshold 
 
            
            
           
if              
 
 
      
     
     
Above the survival threshold the cell 
death rate starts is still zero 
Below 
survival 
threshold  
         
         
         
 
     
     
     
 
If conditions demand cell death, all 
proliferating cells had to become 
quiescent first and all quiescent cells 
die immediately 
Increasing 
cell density 
         
 
     
    
           
Under lack of space the number of 
proliferating cells and cell diffusion 
vanishes. See Table 4 for specifics. 
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Table 3: Transition rates for general situation: Transition rates were given for the amount 1 
of quiescent cells becoming proliferating  , the amount of proliferating cells becoming 2 
quiescent    and for the number of quiescent cells dead     when no concentration 3 
approaches a threshold. Rates were determined by their most restrictive factor    4 
                ,                    ,                     and corrected 5 
for the amount of available space according Table  4. 6 
Limiting factor Condition Transition Parameter Values 
Oxygen Below optimum, but above 
proliferation threshold 
               
           
 
 
 
       
          
 
 
 
            
 
 
 
       
           
   
      
Oxygen Below proliferation, but 
above survival threshold 
            
            
      
Oxygen Below survival threshold 
         
        
   
  
   
 
 
      
       
   
  
   
 
 
Glucose Below optimum, but above 
proliferation threshold 
               
            
 
 
 
       
          
 
 
 
           
 
 
 
       
          
 
 
 
      
Glucose Below proliferation, but 
above survival threshold 
            
       
         
      
Glucose Below survival threshold 
         
        
   
  
   
 
 
      
       
   
  
   
 
 
Waste Below optimum, but above 
proliferation threshold 
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Waste Below proliferation, but 
above survival threshold 
            
        
        
      
Waste Below survival threshold 
         
        
  
   
   
 
 
      
       
  
   
   
 
 
 1 
Table 4: Correction of transition rates in dependence on available space Transition rates 2 
of Equation 4 and Table 3 were corrected for the amount of cell density (cd). Free space was 3 
assumed whenever the total concentration of cells was below           
             , 4 
while full space was assumed was assumed whenever the total cell density exceeded     5 
                     . 6 
             
             
           
 
 
 
      
     
 
 
 
             
       
           
      
     
 
 
 
 7 
Table 5: Boundary conditions for nutrient distributions: Homogenous boundary 8 
conditions were assumed to mimic optimum oxygen and glucose supply as well as maximum 9 
waste disposal for the AVE at the vessel location (           i.e. at the vessel surface). 10 
Migration of cells between the vessel and the tumour were disregarded. Likewise, no flow of 11 
cells and nutrients waste was assumed. However, source term correction for cells and 12 
nutrients was considered as described in the text. 13 
Boundary condition at vessel 
Boundary condition at 
surface 
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Abstract: 1 
Computer models allow the mechanistically detailed study of tumour proliferation and its 2 
dependency on nutrients. However, the computational study of large vascular tumours 3 
requires detailed information on the 3-dimensional vessel network and rather high 4 
computation times due to complex geometries. This study puts forward the idea of 5 
partitioning vascularised tissue into connected avascular elements that can exchange cells and 6 
nutrients between each other. Our method is able to rapidly calculate the evolution of 7 
proliferating as well as dead and quiescent cells, and hence a proliferative index, from a given 8 
amount and distribution of vascularisation of arbitrary complexity. Applying our model, we 9 
found that a heterogeneous vessel distribution provoked a higher proliferative index, 10 
suggesting increased malignancy, and increased the amount of dead cells compared to a more 11 
static tumour environment when a homogenous vessel distribution was assumed. We 12 
subsequently demonstrated that under certain amounts of vascularisation, cell proliferation 13 
may even increase when vessel density decreases, followed by a subsequent decrease of 14 
proliferation. This effect was due to a trade-off between an increase in compensatory 15 
proliferation for replacing dead cells and a decrease of cell population due to lack of oxygen 16 
supply in lowly vascularised tumours. Findings were illustrated by an ectopic colorectal 17 
cancer mouse xenograft model. Our presented approach can be in the future applied to study 18 
the effect of cytostatic, cytotoxic and anti-angiogenic chemotherapy and is ideally suited for 19 
translational systems biology, where rapid interaction between theory and experiment is 20 
essential. 21 
 22 
  23 
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Introduction 1 
Vascularisation of tumours is essential for their progression and, therefore, several 2 
therapeutic strategies seek to target tumour vessels [1-3]. As a consequence, studying how the 3 
structure and amount of vessel penetration give rise to differing tumour proliferation patterns 4 
is of theoretical [4, 5], diagnostic [6, 7] and therapeutic interest [8, 9]. For such studies, 5 
mathematical and computational approaches are often applied [7, 10-14]. However, most of 6 
the existing models confine themselves to the study of avascular tumour proliferation. In turn, 7 
when models consider the detailed impact of the vessel network and the resulting supply of 8 
nutrients and waste disposal, they become mathematically complex, require high 9 
computational resources and are challenged by the incorporation of complex experimental 10 
data. Hence, such models are often impractical for systems biology, where a rapid cycle of 11 
theoretical predictions and experimental findings is required to obtain new biological insight 12 
[15, 16]. 13 
A technically simple and elegant method to study the interaction of cells and their vascular 14 
environment are cellular automata [17, 18], which are often combined with differential 15 
equation approaches. As such, Patel and colleagues [19] implemented a numerically fast, 16 
partial differential equation-based approach to calculate the spatiotemporal distribution of 17 
nutrients such as oxygen, glucose and disposal of waste (lactate) dependent on the vascular 18 
supply. This approach was combined with a 2-dimensional cellular automata model to study 19 
the distribution of proliferating, quiescent and dead tumour cells and their dependence upon 20 
nutrient supply via blood vessels. However, the benefit of simplicity came at the cost of 21 
disregarding information about the vascular structure, which would require a computationally 22 
extensive 3-dimensional cellular automata approach such as the one presented by Welter [13, 23 
14].  24 
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The aim of our study was to construct a model that includes first principle biophysical 1 
constraints on cellular migration, nutrient consumption, cell proliferation and cell death. We 2 
therefore built upon the ideas of Patel [19] and the work of the Galinsky group [11, 12]. 3 
Instead of taking into account extended complex vessel structure of an entire tumour, 4 
however, we assumed the existence and interplay of small avascular volume elements 5 
(AVEs) that make-up the tumour. Amount of vascularisation and its grade of heterogeneity 6 
can then be taken into account by different distributions of AVEs with different sizes. The 7 
AVE size distribution can then be used to calculate the number of proliferating, quiescent and 8 
dead cells in the tumour. We subsequently used the model to identify, and mechanistically 9 
explore, diverse hypotheses that relate vessel density and distribution to amount of tumour 10 
cell proliferation. We finally experimentally illustrate the presence of these novel findings by 11 
a de novo mouse xenograft model.  12 
 13 
14 
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Results 1 
A model to study vascularised tumours via decomposition into avascular elements 2 
We pursued a pragmatic approach for studying vascular tumour proliferation that is suitable 3 
for rapid hypothesis testing. We assumed a certain vascular tumour tissue which we 4 
decomposed into avascular elements (AVEs; Fig 1A).  We modelled that these AVEs 5 
exchange nutrients such as glucose, oxygen, and lactate (waste), together with cells via 6 
adjacent AVEs not separated by vessels (Fig. 1B). We reasoned that the relative AVE size 7 
distribution contains sufficient information to characterise the density and heterogeneity of 8 
tumour vascularisation (Fig 1C, having 10 different AVE sizes). For mathematical and 9 
computational simplicity, AVE’s were assumed as half cylindrical volumes with height 10 
equalling their diameter and a vessel at its centre (Fig 1D). Using this decomposition, we 11 
have transformed the problem of vascular tumour proliferations to the interplay of multiple 12 
AVE of a simple geometry, allowing us to reuse modelling methods, previously applied to 13 
study avascular cell proliferation [10, 20, 21]. Following these approaches, we studied the 14 
distribution of proliferating (P), quiescent (Q) and dead (D) cells within each AVE. We were 15 
interested in the relative composition of these cells within a given tissue rather than studying 16 
absolute tumour size. This was due to the fact that we regard a high proliferative index (the 17 
amount of proliferating cells per given tissue) as a means of tumour aggressiveness, leading 18 
to metastasis and relating to a worse prognosis [22-24]. We considered changes in each 19 
tumour cell type by transition rates. These transition rates were made dependent on oxygen, 20 
glucose and lactate concentrations and amount of available space for cell proliferation (Fig 21 
2AB, Supplementary Figure 1AB, Table 3 and methods). Exchange between AVE’s was 22 
integrated by allowing a net flow of nutrients, waste and cells between AVE’s of different 23 
size, accounting for inter AVE gradients. This exchange is indicated by the arrows in Fig 1B. 24 
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Given that, in turn, this net flow was dependent on the actual nutrient and tumour cell 1 
concentrations of all AVEs, an iterative procedure was pursued to solve the equations. The 2 
used workflow is shown in Fig 2C and described in detail in the method section. The entire 3 
procedure was repeated for each tissue with a given vasculature. 4 
 5 
Calculation of an exemplary AVE size distribution from a virtual tissue as model input 6 
The relative AVE size distribution is the model’s starting point. Such AVE size distribution 7 
can be obtained from 2D and 3D images of entire tissues by any classical tiling approach [18, 8 
25, 26]. For our subsequent calculations, we however opted for a simpler procedure. The 9 
detailed procedure is described in the methods and was used for the entire calculations. We 10 
thereby generated an artificial 2D tissue. In this tissue, we distributed points that represent 11 
vessel, assuming inter vessel distances (IVD) that were taken from histology of colorectal 12 
carcinomas [27]. We subsequently used an algorithm to calculate the distance for each point 13 
of this artificial tissue to the nearest vessel, giving us a histogram for AVE sizes. We 14 
specifically assumed an average inter vessel distance of 75 M, but with different 15 
heterogeneity in vascular structure (Fig 3AB). In the remainder of the manuscript we will 16 
refer to them as homogeneous and heterogeneous vasculature (Fig 3C, red and black bars).  17 
 18 
The model predicts increased cell proliferation and death upon higher vessel 19 
heterogeneity 20 
Having determined a distribution of AVE sizes that represent a homogenously and 21 
heterogeneously vascularised tissue with the same average IVD (Fig 3C), we then 22 
investigated the effect of the different amount of vascularisation on the distribution of 23 
proliferating, quiescent and dead cells. We found that, while a homogenous tissue leads to 24 
very little proliferation and only limited cell death, a heterogeneous distribution led to 12% 25 
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cell death and 10% proliferating cells (Fig 3D). To investigate this further, we looked at the 1 
distribution of P, Q, and D cells in AVEs of different types. In the homogenous tissue, we 2 
observed some cell death in the larger AVEs 6-10 (Fig 3E), but this effect was greatly 3 
diminished once weighting over the volume distributions for AVES of the entire tissue (Fig 4 
3F; bars equal to 100%). In contrast, looking at AVEs of a heterogeneous tissue, we found 5 
markedly more proliferation in the smallest AVE and more cell death in the larger ones (Fig 6 
3G), such that the effect of proliferation and death was preserved when the contribution of 7 
each AVEs to the entire tissue was assessed (Fig 3H). Moreover, a small effect of 8 
proliferative compensation, whereby dead cells are replaced by nascent cells was observed in 9 
larger AVEs (small black area in Fig 3G) and also contributed slightly to the overall higher 10 
rate of proliferating cells in a heterogeneous tissue (Fig 3H). We conclude that a higher 11 
heterogeneous tissue leads to spatial areas with high cell proliferation and high cell death as a 12 
consequence of having rather small and rather large AVEs. In contrast, a homogenous tissue 13 
led to a high amount of quiescent cells due to a modest distribution of AVE sizes causing no 14 
significant compensatory proliferation of dead cells (see illustration in Supplementary Figure 15 
1CD). 16 
 17 
Sensitivity analysis suggests stability of our model to AVE partition 18 
Due to the higher proliferation characteristics of the heterogeneous tissue, suggesting higher 19 
tumour aggressiveness, we focussed on this in the further analysis. As certain parameters had 20 
to be estimated in the model, we wanted to consider their influence on the cellular 21 
composition. We therefore increased or decreased each of these 12 parameter by 10% and 22 
calculated absolute changes in relative or absolute cell compositions (see Fig 4AB and 23 
Supplementary Figure 2AB, respectively). This sensitivity analysis revealed that vessel 24 
permeability ( ), oxygen consumption (   ) and the proliferation threshold for oxygen (co PT) 25 
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were fairly influential factors. In addition, the robustness of the model was tested by 1 
increasing the number of AVEs, therefore representing finer grained AVE size distribution. 2 
This yielded a slight decrease of absolute cell numbers compared to the unchanged model 3 
(Supplementary Fig 2C), but, otherwise, lead to almost the same cell compositions when the 4 
number of AVEs was increased (Fig. 4C).  5 
 6 
Model calculation for different IVDs suggests that cell proliferation may increase when 7 
vascularisation decreases  8 
We next investigated the change of cell composition for different vessel densities. We 9 
therefore repeated our calculation of the AVE distribution from a virtual tissue using the 10 
method described before (Fig 3AB) and using a different average IVD as basis. As expected, 11 
calculating the amount of proliferating, quiescent and dead cells, we found that that the 12 
amount of total cells decreased with decreased vessel density (increased IVD), suggesting 13 
that under a very low vessel density, the tumour cannot sustain a large number of cells (Fig 14 
5A). This decrease was matched by a decrease of quiescent cells. However, when analysing 15 
the amount of proliferating and dead cells, we found that their amounts were increasing with 16 
increasing IVD until a peak was reached around an average IVD~80, followed by a 17 
subsequent decrease at higher IVDs. Looking at the predicted oxygen and glucose levels (Fig 18 
5BC), this surprising results could be explained by a trade-off between two effects. Firstly, at 19 
low IVDs, tissue nutrient perfusion was high, and hence amount of cell death and 20 
compensatory proliferation was low. When tissue becomes less vascularised, cells started to 21 
die, while enough supply was available to allow for compensatory proliferation. At higher 22 
IVD, however, oxygen levels fell under the threshold that is necessary for cell proliferation 23 
(Fig 5B small dashed line), leading to decreased proliferation and contributing to a further 24 
decrease in overall cell numbers. However, oxygen levels remained high enough to sustain 25 
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cellular survival (Fig 5B, dotted line) and therefore cell death continued to decrease as 1 
consequence of the decrease in total amount of cells. Finally, cellular glucose levels dropped 2 
while lactate levels increased when the average IVD was increased (Fig 5CD). All entities, 3 
oxygen, glucose and lactate, eventually reached a constant value. This constant value was 4 
established since not only nutrient perfusion of the tissue, but also nutrient consumption (due 5 
to a lower amount of cells) decreased when IVD increased. We further note that the 6 
calculated oxygen and glucose levels were consistent with physiological values [28-30] and 7 
experimental data of 0.08 mM and 5.5 mM as determined by [31]. In addition, we remark that 8 
values of oxygen, glucose and lactate at low vessel densities are consistent with those for 9 
mild hyperglycaemia, acidosis and hypoxia which are likely conditions in less perfused 10 
regions of the outer tumour rim.  11 
 12 
We then investigated the amount of proliferation and cell death in regions close to the 13 
proliferation peak. We therefore selected two average IVD values, IVD = 64 and IVD= 85 14 
and re-used the method of Fig 3AB to calculate vessel distributions associated to each IVD. 15 
We then calculated the amount of proliferating and dead cells. We observed an increase in 16 
cell proliferation of 38% and cell death of 31% (Fig 5E) when the average IVD was increased 17 
from 64 to 85. Analysing the relative contribution from each AVE between both 18 
distributions, we found that the increased proliferation was observed mainly in the smallest 19 
AVE. In contrast, the amount of dead cells was found in medium and larger AVE, together 20 
with a small concomitant increase in compensatory proliferation (Fig 5FG). We note that the 21 
assumption of a 37% increase in the average IVD between IVD = 64 and IVD= 85 (which is 22 
around the published value of IVD =75) [27] will be useful in the subsequent experimental 23 
analysis. 24 
 25 
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Decrease of micro vessel density is linked to increased tumour proliferation in 1 
subcutaneous HCT116-luc2 tumour  2 
Our modelling results provided evidence that an increased proliferation can be present even 3 
under decreased vascularisation (i.e. increased IVD) within certain vascularisation regimes. 4 
We therefore were interested if we could illustrate this relation by an experimental case. To 5 
do so, we required a model system for rapid hypothesis testing where the same type of 6 
tumour was analyses under a different amount of vascularisation. We  hence used a mouse 7 
xenograft model established in our laboratory  [32] where human HCT116-luc2 colon cancer 8 
cell lines were subcutaneously (SubQ) implanted into Balb/c nude mice.  We sacrificed mice 9 
at day 8 (n = 2) and day 18 (n = 2) post-implantation and analysed tumours histologically in 10 
10 independent fields of the outer tumour rim from 2 mice at each time point.  11 
We first used IHC staining with PECAM1/CD31 antibody to determine the microvessel 12 
density (MVD) which is an experimental measure of the level of vascularisation and which 13 
has an inverse relationship to the IVD we used in the model. We observed a significant (p = 14 
0.006) decrease in MVD of about 27 % from 22.4 ± 2.4 (day 8) to 16.3 ± 2.0 (day 18) (Fig. 6 15 
A-C).  16 
The observed decrease in MVD in our SubQ model may be the result of increased 17 
biomechanical forces and vessel instability from day 8 to 18 as suggested by theoretical 18 
studies [33]. However, we were not interested in rigorously further pursuing this effect, but 19 
aimed to check the emergent consequence of this MVD decrease on the amount of 20 
proliferating and necrotic cells. We note that this decrease in MVD of 27% between day 8 21 
and day 18 translates to an increase of IVD of 37% such as the one from IVD=64 (day 8) to 22 
IVD=85 (day 18) as assumed by Fig 5. 23 
We therefore repeated the analysis on the same tumours using KI67 staining for proliferating 24 
cells and TUNEL staining of cells dead by apoptosis, which is the predominant type of cell 25 
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death in the outer rim region. Interestingly, despite decreased MVD, we identified a 1 
significant (p = 0.0006) increase in cell proliferation from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 2 
% (day 18) (Fig 6 D-F). This 44% increase in proliferation was a bit higher than model 3 
predictions of increased proliferation of 38% that was calculated from our model when IVD 4 
was increased from IVD=64 to IVD=85. Likewise, TUNEL apoptosis staining from ten 5 
independent fields of the same tumours revealed a non-significant (p = 0.098) increase of 6 
number of TUNEL-positive cells per field of view from 5.8 ± 0.7 (day 8) to 8.0 ± 0.8 (day 7 
18), reflecting an 38% increase that coincides with a model prediction of a 31% increase (Fig. 8 
6 G-I).  9 
10 
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Discussion 1 
In this study, we developed a method to investigate how complexity and amount of vessel 2 
structures is correlated with tumour cell proliferation and death within a tissue. The benefit of 3 
this approach lies in its easy integration of experimental data, numerical speed and in the fact 4 
that neither large scale geometric information nor sophisticated numerical calculations are 5 
needed, allowing for a rapid cycle between theoretical predictions and preclinical validations. 6 
The input to our approach are size distributions of avascular elements (AVE’s) that give 7 
abstract information about vessel density and grade of heterogeneity at certain time points of 8 
the tumour. We wish to highlight here that our approach is therefore independent of the way 9 
these distributions are calculated. Here, we generated an AVE size distribution by applying a 10 
simple tiling method using stochastic seeding of test points and investigated the distance to 11 
the nearest vessels. For this specific method we assumed vessel distribution along a simulated 12 
2D tissue. Hence, we did not take into account physiological branching structures, whereby 13 
larger vessels branch successively into smaller ones in a tree-like fashion to guarantee 14 
optimal nutrient support [34]. Therefore, any method to calculate AVE size distributions from 15 
realistic vascular tumours would require more sophisticated approaches in a 3D space [25, 16 
26] such as Voronoi tessellation [18]. Nevertheless, such a physiologically homogenous 17 
vessel branching would also be expected to have a lower dispersion of AVE volume sizes 18 
than a heterogeneous one [35], exactly such as in our approach.  19 
The developed model predicts that tumours with a heterogeneous vessel distribution exhibit 20 
higher proliferation and more cell death compared to tumours with equal vessel densities and 21 
a more homogeneous vessel distribution. This is due to a higher spread of the AVE size 22 
distribution for tissues with higher heterogeneity resulting in areas with a high nutrient 23 
supply, and thus greater proliferation, but also areas with low nutrient supply and cell death. 24 
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Our predictions are consistent with experimental findings from mouse mammary xenografts 1 
where tumour cell proliferation was mainly observed close to areas surrounded by vessels 2 
[36]. Because of their higher cell turnover (more cell death and consequent higher 3 
compensatory proliferation), tumours of heterogeneous tissues may thus have higher 4 
mutation rates, better genetic adaptation and higher aggressiveness. It is therefore tempting to 5 
speculate that by reducing heterogeneity as done by VEGF-inhibitors such as Avastin, 6 
mutational rates may be lowered in highly heterogeneously vascularised tumours and, hence, 7 
malignancy may be mitigated or tumours may be more amenable to standard treatments [37-8 
39]. 9 
 10 
Using the gold-standard HCT-116-SQ mouse xenograft, we have observed a decrease in 11 
MVD of tumours in the colorectal cancer model employed. While this result warrants a more 12 
rigorous investigation, a similar finding has been observed previously by Hemmerlein 2001 13 
et al [40]. It was, however, not our aim to investigate vascularisation kinetics during tumour 14 
growth or even compare our mouse model to others, as this would have required a larger 15 
scale investigation. For our approach this change in MVD was a convenient choice to study 16 
the effects of changed microvessel density on the cell proliferation in a tumour.  17 
 18 
Our modelling approach qualitatively reflected the trend of our mouse model that vessel 19 
density negatively correlates with tumour proliferation under some regimes of 20 
vascularisation. The effect was explained by a trade-off between increase in compensatory 21 
proliferation for replacing dead cells and a decrease of cell population due to lack of oxygen 22 
when nutrient perfusion gets low. Our combined model and experimental efforts therefore 23 
suggest that the apparently trivial relationship between increased vascularisation and 24 
proliferation does not necessarily hold for all situations. Consistent with our findings, Lee 25 
 Vascular tumour models studied by avascular elements 
 14  
and co-workers found an inverse correlation between microvessel density and numbers of 1 
apoptotic cells in mammary ductal carcinoma. They further reported an inconclusive 2 
relationship between microvessel density and proliferation [9], disputing the notion that 3 
vascularisation is intrinsically linked to higher proliferation in all vascularisation regimens. 4 
Besides these qualitative predictions, we predicted quantitative changes of oxygen, glucose 5 
and lactate during changes of the IVD which can be validated in follow-on experimental 6 
studies. Specifically, we note that our values of 50-150 nmol/cm
3
 oxygen (0.05-0.15 mM), 3-7 
4.5 mol/cm3 glucose (3-4.5 mM) and 1-2.4 mol/cm3 (1-2.4 mM) of lactate are in excellent 8 
agreement with physiological levels of glucose 2-5 mM and lactate (0.5-2.2 mM; [28]) in 9 
blood and with oxygen and glucose levels from Jiang et al [31] of 0.08 mM and 5.5 mM.  10 
 11 
   12 
The validity of our model is confined to studying the proliferation characteristics in the outer 13 
rim of the tumour. Specifically, we neglected the necrotic core which is the most decisive 14 
factor for tumour expansion. Taking into account the necrotic core would have resulted in 15 
discontinuous AVE size distribution with the necrotic core as one large AVE that is 16 
connected to several smaller ones. This would have violated our assumption that all AVEs 17 
are continuously distributed and connected with each other in an equal manner. Moreover, 18 
the high space demand in the tumour core would require us to take into considerations high 19 
biomechanical forces which would be at odds with our model of free nutrient diffusion and 20 
the simple convective-diffusive transport of cells (Equations 4-5). Therefore, instead on 21 
focussing on tumour expansion, we rather investigated the proliferative index of a given 22 
tissue. Indeed, the KI67 proliferative index is positively correlating with tumour grade, 23 
metastasis and worse prognosis in solid tumours [22-24], rendering the fact that cancer dead 24 
is more related to the propensity of metastasis than with growth of the primary tumour [41, 25 
 Vascular tumour models studied by avascular elements 
 15  
42]. Likewise, Vartian and Weidner observed that KI67 staining in the tumour cores of 1 
samples from patients with breast carcinomas was 45-fold greater than in adjacent tissue [7], 2 
demonstrating the relevance of this parameter for tumour progression 3 
 4 
Other models have been developed to study the effects of vascularisation using cellular 5 
automata [13, 19, 43, 44], stochastic differential equations [45] or multiphase model 6 
approaches [46, 47]. Even if they were experimentally validated, such models are often 7 
restricted to the study of tumour spheroids and not applied to the study of vascularised 8 
tumours [10, 21]. Indeed, approaches using cellular automata easily become computationally 9 
complex and cannot be applied for studying larger tumours. In contrast, our presented model 10 
can be studied with the same mathematical and numerical formalism for tumours of different 11 
sizes. As our tiling method for studying AVEs may require finer granularity for larger and 12 
more heavily vascularised tumours, restrictions in tumour size may only apply indirectly. 13 
Nevertheless, the computational effort of our algorithm scales with linear power in the 14 
number of different vascular elements N for the equations 1-3 and has only quadratic 15 
dependency on the amount in the exchange term equation 4-9, which for the current 16 
calculation consumed less than 10 % of calculation time. This may become prominent for 17 
higher values of numbers of AVEs. In contrast, Cellular Automata approaches scale with the 18 
cubic power of the number of grids used per tumour length. This together with the smaller 19 
numbers of AVEs compared to the amount of grids gives our approach an advantage over 2D 20 
and especially 3D Cellular Automata approaches with respect to numerical costs. 21 
 22 
In conclusion, the model concededly has its limitations. Firstly, as the model cannot account 23 
for studying growth of the necrotic core, it cannot be used to assess the size of the tumour, 24 
but focuses rather on studying a proliferative index dependent on amount and type of 25 
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vascularisation. Secondly, we modelled only tumour cells and not tumour stromal cells. 1 
Hence, the formalism shall be adapted when other regions than the proliferative tumour rim 2 
are modelled such as adjacent adipose tissue which would have other metabolic and 3 
proliferative rates. We further only provided a qualitative estimation of cell and nutrient 4 
exchange terms (Eq. 4 and 5) and this formalisms may be further improved once a theory of 5 
convection and diffusion of cells and nutrients is available. We finally mostly refrained from 6 
going into predictions on a too quantitative level. We rather used the model as a tool to assess 7 
potential relevant qualitative effects that arise during tumour proliferation as consequence of 8 
different amounts and different heterogeneity of vascularisation. Indeed, we are not entirely 9 
sure that all parameters to remodel a quantitative proliferative response are experimentally 10 
known and controlled, and hence only focussed on those experimental parameters that are 11 
currently widely accepted to control tumour proliferation. Despite these drawbacks, we 12 
provide here a pragmatic model that includes first principle biophysical constraints. With this 13 
concept, we were able to tackle the complex problem of vascular tumour proliferation by 14 
decomposing the tissue into avascular elements, allowing us to reuse concepts from 15 
modelling spheroids. We preferred this first-principle, qualitative approach over a merely 16 
fitting exercise where parameters are adapted to correct for the inevitable model abstractions 17 
of a highly simplified model. We demonstrated that this model concept can serve as a 18 
template for analysis of experimental tumour models and that it was even possible to render 19 
trends of cell proliferation and cell death under altered vasculature. We present this approach 20 
to the readers of JTB for further elaboration by the biophysical community in follow on 21 
studies. In the future, our approach can be extended to integrate mechanisms of tumour vessel 22 
development [25, 26] or to include the effect of cytotoxic and cytostatic chemotherapy, which 23 
could be simply implemented by making the cell transition rates of Fig. 2B dependent on 24 
drug action. Likewise, it would allow the study of anti-angiogenic drugs by modelling their 25 
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impact on tumour vasculature and exploiting the model to assess changes in tumour cell 1 
composition. 2 
3 
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Methods 1 
Ethics statements 2 
All animal experiments were performed by licensed investigators in accordance with animal 3 
research guidelines (Department of Health and Children, Dublin, Ireland) and protocols were 4 
approved by the Animal Research Ethics Committee at University College Dublin, where the 5 
work was performed. Animals were housed in groups, maintained on a 12 hour light/dark 6 
cycle, with access to food and water ad libitum.  7 
Modelling vascularised tumours by decomposition into avascular elements 8 
A semi-phenomenological approach was chosen to account for the influence of the vascular 9 
system. Thereby, the vascular system was assumed to serve as source and drain for nutrient 10 
and waste and thereby affect tumour proliferation [11]. To facilitate calculation of nutrient 11 
supply and waste removal, the complex 3-dimensional vessel structures was replaced 12 
assuming the tissue to be composed of avascular elements (AVEs). An illustration of the 13 
concept is given in Fig. 1A-B. AVE volumes with the characteristic radius      and their 14 
relative fractions were estimated by the following procedure. AVEs were assumed to have a 15 
geometry that is simplified to half cylinders whose height equalled their diameter. A vessel 16 
with a constant radius was assumed to be located at the cylinder’s centre (Fig 1D). Due to this 17 
approximation cylindrical coordinates and periodic boundary condition (Table 5) could be 18 
used, allowing for a simplified (i.e., one dimensional) calculation of nutrient and cell profiles 19 
within the AVE volume. The relative fraction of AVEs of different sizes, (i.e., the AVE size 20 
distribution), represents the underlying vessel structure such as vessel density and regularity. 21 
The AVEs were assumed to be connected with each other to allow the exchange of cells, 22 
nutrients, and waste. Mathematically, this exchange was incorporated with the aid of the 23 
exchange source terms in the PDEs as described below. Boundary conditions according to 24 
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Table 4 were assumed to model transport of nutrients/waste out of/into blood vessels. The 1 
transport dynamics was made dependent on the concentration gradient at the vessel wall and 2 
its selective permeability as in [19]. Migration of cells between the vessel and the tumour was 3 
disregarded. 4 
 5 
Quantification of relative occurrence of avascular elements 6 
To obtain an AVE size distribution from intervessel distances (IVD), we created a 2D virtual 7 
tissue whereby we spotted virtual vessels with the given IVD (=75 µm) and with a vessel 8 
diameter (             m) that reflected previously published data (Fig. 3AB) [27]. To 9 
generate homogeneously and heterogeneously virtual tissues of the same vessel density, spots 10 
(representing the vessels) were equidistantly distributed for both tissue types. In the case of 11 
the heterogeneous tissue, twice as many spots were placed initially and half of them were 12 
removed arbitrarily to create an irregular pattern. In order to obtain the AVE size distribution 13 
that represents a tissue, 10 000 test points were randomly placed into the virtual tissues. 14 
Afterwards, distance distributions of these points from the two nearest vessels were 15 
determined (       ), and the characteristic length of an AVE was defined by         16 
            AVEs were binned into 10 equally spaced containers according their 17 
characteristic radii                                         ;         = 76 m, 18 
        = 103 m for homogenous and         = 61 m,         = 204 m for 19 
heterogeneous tissue) leading to a histogram of relative occurrence   , hist      :=   20 
               .  21 
Finally, to account for the fact that randomly placed points have a greater likelihood to be 22 
counted by this procedure due to their larger area [48], the probability distribution of the 23 
recorded histogram       was weighted by the AVE cross section 24 
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                      with           
           
 . The relative occurrence of 1 
AVEs in the tissue         is plotted in Fig 3C, whereby homogenously and 2 
heterogeneously vessel distribution differed in the spread of the covered range of 3 
characteristic radii. From the characteristic radii, AVE volumes were created according to the 4 
formula of half cylinders with same height as diameter Voli =          
          
     5 
       . The volume distribution is hence characterised by those from the corresponding radii 6 
with an x-axis that scales with the third order of the radii.  7 
As mentioned above the vessel homogeneity in this paper denotes an average distribution of 8 
vessels in two dimensions, and not a physiologically observed 3-dimensional tree-based 9 
vessel structure. 10 
Dynamic equations of oxygen, glucose, waste and tumour cell types within AVEs 11 
To calculate the dynamics of nutrients, waste and tumour cells within a particular AVE, a 12 
framework as frequently applied to tumour spheroids was followed. Therefore, tumour 13 
proliferation profiles within each AVE were calculated by determining spatiotemporal 14 
profiles of different tumour cell types. Consistent with approaches in [49, 50] the number of 15 
proliferating (P), quiescent (Q) and dead (D) cells (as a collective term for all types of cell 16 
death) per volume unit was assumed. Their evolution was influenced and in turn influences 17 
the availability of glucose (g), oxygen (o) and waste (w, lactate within this work).  18 
Oxygen, glucose, and waste were assumed to penetrate via the vessels walls. While oxygen 19 
and glucose are consumed, waste is produced by proliferating or quiescent tumour cells (P, 20 
Q). The temporal (time t) and spatial (radius of the AVE r) evolution of their concentration co 21 
(r,t), cg (r,t) and cw (r,t) within each AVE is given by the following-reaction diffusion 22 
equations:  23 
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 1 
   
  
                       
   
  
                       
   
  
                      
 
 
 
Equation 1 
In the partial differential equations (PDEs) in Equation 1 the first term on the right hand side 2 
describes the diffusion of oxygen, glucose and waste with respective diffusion constants 3 
  ,  ,  , assuming that these entities diffuse homogenously through the entire tissue. The 4 
entities   ,   ,    denote the source terms that account for change of oxygen, glucose or waste 5 
by their turnover (consumption or production) and the diffusive exchange of oxygen, glucose 6 
or waste among AVEs (via exchange terms as described later).  7 
The source terms of Eq. 1 were modelled by 8 
                         
                         
                        
 
 
Equation 2 
whereby oxygen and glucose were consumed by proliferating P (with rate per cell of     and 9 
   ,, respectively; Table 1) and quiescent cells Q (with rate per cell of     and    ; Table 1). 10 
Likewise,     and     were the rate of waste production by proliferating and quiescent cells, 11 
respectively. The terms         ,         ,         were denoted in this paper as AVE 12 
exchange source terms and account for the exchange between AVEs of different size as 13 
subsequently described.  14 
The spatiotemporal concentration of all cell types (P(r,t), Q(r,t), D(r,t)) was modelled by 15 
 16 
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Equation 3 
with c denoting the dependency of above parameters on oxygen, glucose and waste 1 
concentration as described below. As before, all cell types were modelled to diffuse within 2 
the extracellular matrix as given in the first term on the right hand side of each equation and 3 
characterised by the effective diffusion constants Dp, Dq and Dd. These diffusion constants 4 
were modelled to depend on the total cell density (        ) to account for diffusion 5 
impairment due to increased cell crowding following the approach of Gatenby [11, 12]. Here, 6 
the density-dependent effective diffusion coefficients were defined as           7 
                                   . We thereby set        
     
     
   8 
      to obtain a stable decaying function with cell density cd and used the constant 5 to 9 
have diffusion sufficiently blocked at maximum cell densities       (<1% of max). 10 
Further terms at the right hand side of Equation 3 characterise the transition of cells between 11 
of different types (P, Q, D) as illustrated in Fig. 3A. For these terms in Equation 3 the 12 
transition parameter   denotes the rate of cell birth,    the rate at which proliferating cells 13 
become quiescent,    the rate at which quiescent cells become proliferating,    the rate of 14 
quiescent cells dead and    accounts for the disintegration and removal of dead cells which 15 
was assumed to be                      . The factor 100 cm
-1
 was assumed to allow 16 
for a moderate dependency with AVE size (as      was given in cm for our calculations, 17 
therefore the exponential factor varied around 1 for a typical AVE). The factor Kr (Table 1) 18 
was assumed to reflect a half time of degradation of 1.5 h which was considered as the typical 19 
time for phagocyting dead cells.  ,   , and    are described below.   , was constant while 20 
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   was made dependent on the AVE size to account for slower removal rates and response 1 
times (e.g. due to macrophages clearing the cellular debris) in the case of bigger AVEs.  2 
 3 
Transition rates between tumour cells and their dependency on nutrients, waste and cell 4 
density 5 
According to a procedure as given in [49, 50], tumour cells of different kinds were assumed 6 
to change their state as given in Fig 2. The respective transition rates for cell proliferation   , 7 
for proliferating cells becoming quiescent    and for quiescent cells to die    were modelled 8 
to be dependent on the cell density, and the concentration of oxygen, glucose and waste. 9 
Three different types of thresholds for oxygen, glucose and waste levels were introduced to 10 
incorporate the combinatorial effect of different nutrient/waste concentrations (see Table 1) 11 
on cell transition. These were the survival thresholds (             , proliferation thresholds 12 
(                 and a threshold for optimal conditions (                     For the making the 13 
transition rates dependent on nutrient and waste distribution (i.e.,        and   ), three 14 
specific conditions, denoted here as limit conditions, were assumed as follows:  15 
 16 
Rates under condition of cell death: Whenever either oxygen or glucose supply was assumed 17 
to fall below (                 , or waste was to exceed (       ), the respective 18 
survival thresholds, proliferating cells were assumed to become quiescent and quiescent cells 19 
were assumed to die                  . The following rules for transition rates at 20 
the different thresholds apply: 21 
 22 
Rates at the proliferation threshold: Whenever oxygen and glucose were exceeding the 23 
respective proliferation thresholds (                   , and the waste level was 24 
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undergoing the latter (        ), quiescent cells were modelled to become proliferating 1 
       and the rate of cell death was assumed to be zero        . 2 
 3 
Rates at and above the threshold for optimal proliferation: When, at the same time, oxygen 4 
and glucose concentration were above and waste concentration below the threshold for 5 
optimal conditions (  ≥       ,   ≥       ,            ), proliferation was maximum and rates 6 
for cells becoming quiescent or dead were zero       ,          ).  7 
 8 
These limit conditions for cell transition rates are summarized in Table 2. Values for   , 9 
  ,   between these limit conditions were interpolated via steady, differentiable, and 10 
monotonous functions of these transition rates for the entire range of glucose, oxygen and 11 
waste concentration. Therefore, cosine and sine functions scaled to the descending and 12 
ascending quadrant were chosen to have everywhere differentiable function that reflect the 13 
monotonous dependency of transition rates on the concentrations of nutrients and lactates  14 
(Table 3). Supplementary Figure 1AB depict how    and    depend on oxygen and glucose.  15 
Furthermore, we assumed cell transition rates to be dependent on the cell density. Cell 16 
proliferation was only possible if the cell density    was below the maximum density 17 
           
              according to [12]. This value is in good agreement with those 18 
obtained for EMT6/Ro tumour spheroids (                       ; [51]). To avoid 19 
that continuous cell proliferation could lead to cell densities higher than maximum value 20 
       the transition rate    was made to decrease and    to increase with increasing cell 21 
densities (        ) as described in Table 4. Likewise, the factor in KQ in Table 4 was 22 
chosen to restrict the total amount of cells to        23 
Calculation of the AVE exchange source terms         24 
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AVE’s of different sizes were assumed to be connected to each other (and are not fully 1 
separated by the vessel network). Therefore, cells, nutrients and waste were assumed to 2 
exchange among AVE’s of different volumes. Consequently, disequilibrium in cells, 3 
nutrients and waste results in a net flow of the latter between adjacent AVEs. We assumed 4 
that all AVEs were connected equally with each other, according to their relative 5 
occurrence       . This net flow was introduced in Equation 2-3 and denoted as exchange 6 
source terms      .  7 
Within the following we describe how the exchange source terms for oxygen and for 8 
proliferating cells (         and         , respectively) were calculated at each iteration step, 9 
assuming above average nutrient, waste or cell concentrations to be known. Calculations of 10 
source term corrections for glucose             and waste (          and other cell types 11 
(                 follow the same scheme. These exchange terms were assumed to be 12 
spatially independent. Therefore, the        terms could be considered to be constant over the 13 
entire distance of exchange which is the sum of the characteristic length             of 14 
adjacent AVEs. 15 
We first determine transfer rates for dissolved species such as nutrients and waste between 16 
AVEi and AVEj. We note that this exemplary choice of two AVEs does not require any 17 
specific spatial arrangements or other constraints, besides being of different size.  18 
As example we calculated the oxygen exchange rate         which was assumed to be 19 
dependent on the gradient between the average concentrations in the AVE (               ) as 20 
              
               
               
    
Equation 4 
 21 
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Equation 4 describes diffusive transport which is based on a flux rate according to Fick’s law 1 
of diffusion. The law assumes particles to move through a virtual area perpendicular to the 2 
diffusion direction and, hence, this flux is inversely proportional to the area spanned by the 3 
radii of both AVEs ([52], Supplementary Text 1). 4 
 5 
In contrast to nutrients and waste where diffusion is quick and dominates the transfer, the 6 
calculation of cellular transfer rates such as proliferating cells (       ) has also to account for 7 
convective transport. This convection is driven by different cellular occupancies leading to 8 
differential space restrictions and consequent pressure equilibration between AVEs. This 9 
generates a diffusion independent convective net flow that is dependent on the difference of 10 
cell densities in each AVEs (       ), but independent of the actual cell type (i.e. not driven by 11 
entropy). Consequently, we combined the diffusion term, here shown for proliferating cells, 12 
with a convective term (on the right side of Eq. 5)  13 
             
             
             
    
    
     
 
               
             
    . 
Equation 5 
We note that this represents a net flux that is analogous to the one of a convection-diffusion 14 
equation [53]. Thereby, the factor (
    
     
) of the second, convective term was adjusted to 15 
render cell occupancies for all AVEs which were assumed to vary only within a reasonable 16 
range of 20% between the smallest (          ) and biggest (          ) AVE. We note that 17 
this term presents solely a heuristic expression for convective transport that is consistent with 18 
above biological assumptions as no current detailed theory of cell convection within tumours 19 
is available. 20 
Above transfer rates were subsequently used to calculate the temporal change (exemplified 21 
here for oxygen) in AVE   and   by weighting the exchange among AVEs according to their 22 
volumes to guarantee conservation of mass (i.e. cells or species) 23 
 Vascular tumour models studied by avascular elements 
 27  
         
  
           
         
                   
      
         
  
           
         
                  
      . 
Equation 6 
By solving Equation 6, the net flow rates (here for oxygen) between two AVEs during a time 1 
step t can be determined as: 2 
                 
                             
  
 , 
Equation 7 
whereby                                  denote the oxygen concentrations at the beginning and 3 
end of a time step. Then, to capture the oxygen exchange between all AVE’s during a time 4 
step, we define the matrix  5 
                    
                           
   
                             
  . 
Equation 8 
We further assumed that all AVEs are equally connected with each other. This assumption 6 
requires that AVE distributions are continuous (i.e. no single large AVE such a necrotic 7 
core). It further requires that the AVEs in any heterogeneous distribution would be rather 8 
statistically distributed within the tissue, while for homogenous distribution (having smaller 9 
differences of AVE sizes) the exchange term would have minor impact. 10 
Finally, the exchange source term of an AVE   (here for oxygen) was obtained by summing 11 
up the exchange with all AVE’s during a time step, weighted by the relative AVE 12 
occurrence           : 13 
                   
 
                  , Equation 9 
Solution and numerical procedure for calculating proliferating, quiescent and death 14 
cells considering inter-AVE exchange 15 
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The differential equations 1-3 that describe spatiotemporal cell distributions within the AVEs 1 
and the equations 4-9 that describe the exchange terms between AVEs form a self-consistent 2 
problem. This means that from spatial distributions of nutrients, waste and P, Q and D cells in 3 
each AVE (as calculated via Eq. 1-3), the AVE exchange terms have to be calculated 4 
according to Eq. 4-9. In turn, the exchange terms feed again into the differential equation 1-3, 5 
requiring the need for an iterative procedure.  6 
The iteration was performed for a small, but finite time interval (       ), for which we 7 
could assume the AVE exchange terms as constant. This assumption of constant AVE 8 
exchange terms allowed to decouple equation 1-3 from equation 4-9 in their time 9 
dependency, facilitating the numerical solution. The iteration at a certain time step was 10 
continued till AVE exchange terms converged. After convergence of AVE exchange terms, 11 
the iteration was started again for the successive time step of the same finite time 12 
interval,       . Therefore, AVE exchange terms can change for successive time steps, but 13 
remain constant during each time interval. The exchange source terms of the first iteration 14 
were initialised using the values of the previous time interval. The workflow of this nested 15 
iterative procedure was shown in fig. 2C. This procedure was repeated until cell densities of 16 
P, Q and D cells did not change (<< 0.1%) during subsequent time intervals. Usually this was 17 
reached after 400 time steps and was greatly independent of initial conditions (used for the 18 
first time interval; see supplementary Figure 3). 19 
We note that above time intervals have a specific biological interpretation within the 20 
framework of the described numerical procedure. The reason is that the procedure assumes 21 
that a certain vasculature is present and that cell compositions and their spatial distributions 22 
adapt over time starting from arbitrary initial conditions. After this adaption, time intervals 23 
refer to the speed of how cell compositions evolve in response to a change in vasculature (a 24 
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disequilibrium that is given between the actual and the optimal spatiotemporal cell 1 
composition). 2 
 3 
Finally, concentration for proliferating (P), quiescent (Q) and dead cells (D) for the entire 4 
tissue were obtained by weighting the P, Q, N numbers of each AVE by the relative 5 
occurrence of the AVE and multiplying by its volume, e.g.  P=          
      
       
. All 6 
calculations were performed using MATLAB R2014 (The Mathworks, UK) using the in-built 7 
PDE solver (PDEPE). Code is provided by the authors on request. 8 
 9 
Calculation of the change of tumour proliferation characteristics for increasing 10 
microvessel density 11 
For model calculations in Fig 3, a heterogeneous vessel distribution as in Fig 3C was used. 12 
AVE size distributions were then calculated using the virtual tissue method as described 13 
above using the IVD as input. The observed experimental decrease of the microvessel 14 
distance between day 8 and day 18 by 27% was reflected by an increase of IVD by 37% due 15 
to the inverse relationship between both (IVD ~  1/MVD; 100% / 137% = 0.73, i.e. 27 % 16 
decrease). IVD values were hence chosen as 64 µm to 85 µm for day 8 and day 18, 17 
respectively, to be centred around the experimental value of 75 µm [27].  18 
 19 
Xenograft model   20 
Xenograft models were established by subcutaneous injection of 2.5 x 10
6
 HCT116-luc2 cells 21 
into the flank of Balb/c nude mice (Charles River Laboratories, UK). Tumours were 22 
harvested at days 8 (n = 2) and 18 (n = 2) and fixed in 10 % buffered formalin for 24 hours 23 
before being processed and paraffin embedded.  24 
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Histologic Examination and Immunohistochemistry 1 
Paraffin-embedded, formalin-fixed tissue sections from mouse HCT116-luc2 subcutaneous 2 
tumours were stained with Hematoxylin and Eosin (H & E) and anti-luciferase stained in 3 
order to access percentage of tumour core necrosis. Anti-KI67 and anti-PECAM1/CD31 4 
staining procedures were carried out to determine tumour cell proliferation and microvessel 5 
density respectively. In brief, tumour sections were deparaffinized with xylene and 6 
rehydrated according to standard histologic procedures. For epitope retrieval, sections were 7 
boiled for 20 minutes in 10 mM citrate buffer, pH 6.0. Sections were rinsed in Tris buffered 8 
saline (TBS)-Tween and blocked in 5 % serum in TBS for 1 hour followed by incubation at 9 
room temperature for 1 hour with the following primary antibodies: rabbit anti-Ki-67 10 
(Millipore, Billerica, MA), dilution 1:100; goat anti-luciferase polyclonal antibody (pAb) 11 
(Promega, Fitchburg, WI), dilution 1:50; and goat anti-PECAM-1 (M-20) (Santa Cruz 12 
Biotechnology, Inc., Dallas, TX), dilution 1:100 in TBS containing 1% serum. Biotinylated 13 
goat anti-rabbit or horse anti-goat secondary antibodies (Vector Laboratories, Burlingame, 14 
CA), dilution 1:200 in TBS/ 1 % serum, were applied for 1 hour at room temperature 15 
followed by ABC complex (Vectastain ABC kit, Vector Laboratories) incubation for 30 16 
minutes. Positive signal was developed with diaminobenzidine (DAKO, Glostrup, Denmark) 17 
according to the manufacturer’s instructions. Sections were counterstained with hematoxylin 18 
to visualize nuclei. TUNEL staining was performed according to manufacturer’s 19 
recommendations using ApoptoTag Peroxidase In Situ Apoptosis Detection Kit (Millipore, 20 
Billerica, MA). For assessment of proliferation indices (percentage of KI-67-positive cells), 21 
fractions of labelled tumour cells were assessed in 10 microscopic high-power fields per 22 
section using x40 magnification and ImageJ software (National Institutes of Health, 23 
Bethesda, MD). While the rabbit anti-KI67 antibody implemented cross-reacts with human 24 
and mouse tissue,  histopathological analysis confirmed that the tumour rim area  (outside the 25 
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necrotic core and the adipose tissue) used for KI67 analysis in Fig 7 were almost exclusively 1 
(>95%) populated with tumour cells at both day 8 and day 18, and cells with a morphology 2 
consistent with infiltrating cells are not discernible. 3 
Microvessel density based on criteria previously described [54] was assessed.  4 
To quantify percentage of tumour core necrosis, whole slides were first scanned on a Leica 5 
microsystems whole slide imaging platform (Leica Microsystems, Wetzlar, Germany) and 6 
then area of tumour core necrosis versus whole tumour area was calculated using ImageJ 7 
software (National Institutes of Health, Bethesda, MD). Alternatively, representative images 8 
of stained tissue slides were captured using a Nikon 2000s epi fluorescence microscope with 9 
a Hamamatsu Orca 285 camera (Micron-Optical, Wexford, Ireland).  10 
Data Analysis 11 
Data are presented as the mean ± standard error of the mean (SEM). Two-group comparison 12 
was made using unpaired t-test or Mann Whitney test (PRISM GraphPad Software In.c., La 13 
Jolla, CA). Significance was accepted at p < 0.05. 14 
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Figure Legends 1 
Figure 1: Schematic representation of the method for decomposing vascular tissue into 2 
avascular elements (AVEs) (A) A vascular tumour is decomposed into different AVEs. 3 
Here four elements of different sizes are illustrated by different colours. (B) These elements 4 
(depicted as rectangles for convenience and colour code relating to (A), indicating different 5 
element sizes) were considered to exchange nutrients, waste and cells via diffusion. The 6 
small arrows indicate the exchange among the elements. Every AVE was assumed to be 7 
connected to an AVE of a different size with a probability proportional to their relative 8 
occurrence (C). This AVE size distribution is characterised by a histogram, whereby AVE’s 9 
are binned according their size. The shape of the histogram is an indicator of the regularity of 10 
the vessel system. (D) AVE geometry was simplified via a half cylindrical shape with a 11 
vessel at the centre and with a height being equal to the diameter of the cylinder. These 12 
assumptions reduced the mathematical complexity of the PDE system. 13 
 14 
Figure 2: Implementation of transition rates and numerical procedure (A) Scheme 15 
depicting the dependency of the three transition rates        and    on oxygen (co), glucose 16 
(cg) and lactate (waste; cw) concentrations at three different conditions. Cell death conditions 17 
(left panel) occur when either oxygen or glucose is below or waste is above a specific 18 
threshold value (Suffix T). Change from quiescence to proliferating cells occurs when 19 
concentrations exceed the proliferation threshold (medium panel; Suffix PT). Optimum 20 
conditions (Suffix opt) are achieved when, at the same time, oxygen and glucose are above 21 
and waste is below a specific concentration threshold (right panel). Between these thresholds, 22 
transition rates were interpolated using sine and cosine scaled to the descending and 23 
ascending quadrant to reflect the monotonous dependency of these rates on nutrients and 24 
wastes. (B) Transitions between proliferating (P), quiescent (Q) and dead (D) tumour cells 25 
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are depicted. Above the proliferation threshold, tumour cells proliferate at rate    and 1 
quiescent cells become proliferating at rate   . Below the proliferation threshold, 2 
proliferating cells become quiescent at rate KQ. Below the survival threshold, quiescent cells 3 
died at rate    and were removed according to a removal rate   . (C) The iterative procedure 4 
to calculate the AVE exchange term is depicted. A nested procedure was used. The inner 5 
iteration was used to solve Eqs. 1-3 along with Eqs. 4-9 at a certain time step t during a time 6 
interval t until AVE source terms were stable. Use of the time interval t allowed to 7 
consider the AVE exchange terms constant with respect to time during this comparably small 8 
interval. This decoupled the Eqs. 1-3 from Eqs. 4-9 in their time dependence and facilitated 9 
the numerical solution. In the outer loop, iteration was performed over subsequent time steps 10 
to account for the time dependency of AVE exchange terms. As starting conditions for each 11 
time step, AVE exchange terms of the previous step were used. The outer integration was 12 
stopped until also convergence for P, Q and D cells was achieved. Finally, the average 13 
number of P, Q and D cells per volume for a specific vascularisation were extracted. 14 
Figure 3: Calculated distribution of proliferating, quiescent and dead cells, and cell 15 
density over time emerging from homogenous and heterogeneous vascularisation (A-B) 16 
The principle of determining the relative abundance of AVEs with a characteristic diameter 17 
RAVE and its application to homogenous and heterogeneous vascularity is given. A virtual 18 
2D tissue was assumed for homogenous (A) and heterogeneous (B) vasculature (red spots). 19 
The distance to the two nearest adjoining vessels         from randomly placed dots was 20 
calculated assigning the characteristic length RAVE = ½ abs(      ) (see magnified graph). 21 
Volumes were calculated according Fig 1D to reflect 3D avascular elements (AVE). (C) 22 
Histograms for AVE distributions using a homogenous (grey bar) or heterogeneous (black 23 
bar) vasculature from the same average vessel density were given as derived from this 24 
procedure. (D) Calculated distribution of proliferating, quiescent and dead cells for a 25 
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homogenous and heterogeneous vasculature (left column) with the same average IVD of 75 1 
m from panel C. While under a homogenous vasculature (E; absolute numbers Q: 4.7 108, P: 2 
1.6 10
6
, D: 5.0 10
5
), the amount of proliferating cells was negligible, a higher amount of these 3 
cells, and therefore a higher cell turnover, was predicted with a heterogeneous distribution 4 
(absolute numbers Q: 3.0 10
8
, P: 5.1 10
7
, D: 3.7 10
7
. (E, G) relative distribution of P (black), 5 
Q (dark grey) and D cells (light grey) in each of the 10 AVEs for homogenous and 6 
heterogeneous tissue, respectively.  Larger AVEs numbers depict bigger AVEs as 7 
characterised by the Radius RAVE from Fig 3C. For the homogenous tissue (E), only quiescent 8 
cells were present in most of the AVEs, while only the two biggest AVEs showed some dead 9 
and proliferating cells. For the heterogeneous tissue (G), proliferating cells were most 10 
prominent in the best perfused, smallest AVE, while dead cells were prominent in larger 11 
AVEs. Notably, compensatory proliferation, whereby dead cells are replaced was noted in 12 
medium size AVEs (proliferating rate higher in AVE 5-8 than in AVE 3). (F, H) Volume 13 
weighted relative distribution of P, Q, D cells for the homogenous (F) and heterogeneous 14 
tissue (H) are given, giving the percentages of cells of each type and in each AVE relative to 15 
the entire tissue (100%).  16 
Figure 4: Sensitivity analysis of the model Parameters that were not obtained from 17 
literature were subjected to a local sensitivity analysis, whereby each parameter was varied 18 
independently by 10%. Parameters are described in Table 1. The heterogeneous distribution 19 
from Fig. 3 was used (average IVD of 75 m). (A-B) Values of P, Q and D cells were given 20 
relative to the tissue and absolute deviation of these relative percentages were calculate when 21 
a parameter was changed by +/- 10 % compared to the one obtained by the reference value of 22 
the parameter of Table 1. The vessel permeability was identified as the most influential 23 
parameter. Only parameters which changed the cell composition by more than 0.1% were 24 
shown. (C) Same as (AB) for the cell compositions when using a different number of AVEs. 25 
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 1 
Figure 5: Change of cell composition over different amount of vascularisation reveals a 2 
peak of proliferating and dead cells around and average IVD of 80 m (A) Cell numbers 3 
for P (black dashed line), Q (dark grey dotted line), and D (light grey solid line) cells were 4 
given for heterogeneous tissues with different average IVDs. While the average amount of 5 
cells per tissue steadily decreased due to lack of nutrient supply, the amount of proliferating 6 
cells reached a peak at about 80 m as the decreasing overall cell number at regimens 7 
between 50 and 80 m allowed for quiescent cells to re-enter a proliferating state. dead cells 8 
matched that trend of proliferating cells. (B-D) Amount of oxygen (B) and glucose (C) 9 
supply together with lactate (waste, D) concentration over different heterogeneous tissues 10 
with given average IVD. Survival threshold, proliferation thresholds and optimal 11 
concentrations for the respective entities are given by dotted, small dashed and large dashed 12 
lines. Notably, oxygen levels cross the optimum proliferation threshold at ~80 m, leading to 13 
a decrease of proliferation at tissues with higher average IVD (lower vessel density). (E) 14 
Comparison of proliferating and dead cells for tissues with average IVDs of 64 and 85 that 15 
are around the peak of proliferating and dead cells. We observed an increase of 38% and 16 
31%, respectively, despite a tissue with lower vessel density. The increase in the average IVD 17 
of 37% matched the decrease of microvessel distance in Fig 6B of 27% due to an inverse 18 
relation between both. (F, G) Volume weighted relative distribution of P, Q, D cells for a 19 
heterogeneous vessel distribution of Fig. 3C and average IVDs of 64 (F) and 85 (G) are 20 
given. The percentages of cells of each type in each AVE are given relative to the entire 21 
tissue (100%).  22 
 23 
Figure 6: Model can predict evolution of tumour cells caused by changes in vascular 24 
density Microvessel density (MVD), proliferation index and number of apoptotic cells were 25 
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detected using a HCT116-luc2 SQ tumour mouse xenograft model and harvesting tumours at 1 
day 8 and 18. (A-C)  Representative images of PECAM1/CD31 staining are given (A-B). 2 
Staining was analysed for two mice for each time point using 10 randomly chosen fields 3 
outside the necrotic core lead to a significant decrease (p = 0.0059) in MVD from Day 8 4 
(22.4 ± 2.4) to Day 18 (16.3 ± 2.2; C). This relative decrease of 27% was considered as equal 5 
to an increase of 37% in the average IVD in our model according to their inverse relation. (D-6 
F) Evolution of proliferating cells between day 8 and day 18. KI67 antibody was used for 7 
staining proliferating cells (D-E). A significant increase (p = 0.0006) of proliferation in day 8 
18 tumours was observed from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 % (day 18), as MVD 9 
decreased (F). This experimental increase in proliferating cells (44%) was matched by the 10 
model (38%). (G-I) Evolution of dead cells from day 8 to day 18 as MVD decreases. 11 
TUNEL-staining of representative fields outside the necrotic core (G-H) indicated non-12 
significant (p = 0.098) increase in number of apoptotic cells (used to compare with the dead 13 
cells from the model) from 5.8 ± 0.7 % (day 8) to 8.0 ± 0.8 (day 18). Increase in dead cells 14 
(38%) qualitatively matched model data (31%). For all staining data bars represent mean ± 15 
SEM (day 8 (n = 10 images per tumour, n = 2 animals), day 18 (n=10 images per tumour, n = 16 
2 animals), quantifications from 10 randomly chosen field of views per section outside the 17 
necrotic core for each of the two mice sacrificed at the indicated dates, scale bar = 25 μm, * - 18 
p < 0.05, ns – non-significant, Mann-Whitney test 19 
 20 
Supplementary Figure 1: Transition rates and cellular distributions 21 
(A-B) Transition rates between P and Q in dependence on glucose and oxygen concentration 22 
relative to their optimal values (cg opt and co opt).  (C, D) Spatial distribution of the different 23 
cell types for the homogenous and the heterogeneous distribution were re-generated by 24 
randomly assigning the AVEs to spatial locations for illustration purposes. Dots were 25 
 Vascular tumour models studied by avascular elements 
 40  
coloured according to the probability of P, Q, or D cells in the particular AVE. Islands of cell 1 
death in the heterogeneous vessel distribution in (D) indicate high accumulation of dead cells 2 
arising from large AVE elements that were insufficiently supplied by nutrients or affected by 3 
high waste accumulation. 4 
Supplementary Figure 2: Extended sensitivity analysis  5 
Each parameter was varied independently by +/-10%. Parameters are described in Table 1. 6 
The heterogeneous distribution from Fig. 3 was used (average IVD of 75 m). (A-B) 7 
Absolute changes of P, Q and D cells were calculated when a parameter was changed by +/- 8 
10 % and given relative to the cell composition obtained when using the reference value of 9 
the parameter of Table 1. The vessel permeability was identified as the most influential 10 
parameter (C) Same as (AB) for the cell compositions when using different numbers of 11 
AVEs. 12 
 13 
Supplementary Figure 3: Stability of our method (Fig. 2C) to initial conditions Different 14 
initial conditions were used for the heterogeneous tissue with AVE=75 of Fig 3 from the 15 
main text and temporal evolvement of P, Q and D cells and the total cell density was 16 
calculated (A-D, respectively). Convergence was achieved at about 100 time steps. For the 17 
interpretation of time steps, please refer to the methods section. 18 
19 
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Tables 1 
Table 1: List of constants used in the model Rates for nutrient consumption, waste 2 
production, diffusion of cells and nutrients, and concentration thresholds for nutrients and 3 
waste for determining cell proliferation and death, were given along with their references. 4 
Constant Description Value/ Source 
                      Oxygen consumption of proliferating cells     
    [51] 
     
                 Glucose consumption of proliferating cells             
  [31, 55] 
                      Waste production of proliferating cells  
   
        
 [31, 55] 
                      Oxygen consumption of quiescent cells  
  
        
 [31, 55] 
     
                 Glucose consumption of quiescent cells           
 [31, 55] 
                      Waste production of quiescent cells  
   
       
 [31, 55] 
            Metabolic rates of dead cells   (assumed) 
      
     Empty space P cell diffusion constant           [31] 
      
     Empty space Q cell diffusion constant        (assumed)  
      
     Empty space N cell diffusion constant 0 (assumed) 
      
     oxygen diffusion constant           [31] 
      
     glucose diffusion constant           [31] 
      
     waste diffusion constant           [31] 
           
   Survival threshold for oxygen  
 
          [31] 
              
   optimal oxygen concentration  
 
          [31] 
            
   Proliferation threshold for oxygen  
     
             
   
 
(assumed) 
        Survival threshold for glucose         
   [31] 
           optimal glucose concentration        
   [31] 
         Proliferation threshold for waste  
    
    
    
 
 (assumed) 
        Survival threshold for waste      
   [31] 
            optimal glucose waste    [31] 
         Proliferation threshold for glucose  
    
    
    
 
 (assumed) 
           Vessel permeability 18.5*Do (assumed) 
 Vascular tumour models studied by avascular elements 
 42  
         Maximal transition rate between Q and P cells 
      
 
 (assumed) 
         
Maximal transition rate between P and Q cells 
(if survival thresholds are not reached) 
      
 
 (assumed) 
   [   ] Rate of cell birth       [49] 
 
        Maximal removal rate of dead cells 
      
   
 (assumed) 
 1 
Table 2: Limiting conditions for cell transition rates: Transition rates for the amount of 2 
quiescent cells becoming proliferating  , the amount of proliferating cells becoming 3 
quiescent    and for the number of quiescent cells dead    were given when different 4 
nutrient and waste concentrations converged against specific thresholds. The conditions are 5 
explained using    as example. 6 
Situation Condition Transition 
Parameter 
Remark 
Approach 
optimum 
concen-
tration 
                 
                 
                  
 
if              
 
     
      
(= maximum 
value) 
     
Under optimal conditions (glucose and 
oxygen above optimum concentration 
and waste below) no proliferating cells 
become quiescent, and quiescent cells 
become proliferating with a constant 
rate 
Approach 
prolifer-
ation 
threshold 
                   
              
              
 
if              
 
 
    
 
 
 
      
     
     
If conditions approach the proliferation 
threshold the transition rate of 
proliferating to quiescent cells becomes 
a constant 
Approach 
survival 
threshold 
 
            
            
           
if              
 
 
      
     
     
Above the survival threshold the cell 
death rate starts is still zero 
Below 
survival 
threshold  
         
         
         
 
     
     
     
 
If conditions demand cell death, all 
proliferating cells had to become 
quiescent first and all quiescent cells 
die immediately 
Increasing 
cell density 
         
 
     
    
           
Under lack of space the number of 
proliferating cells and cell diffusion 
vanishes. See Table 4 for specifics. 
 7 
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Table 3: Transition rates for general situation: Transition rates were given for the amount 1 
of quiescent cells becoming proliferating  , the amount of proliferating cells becoming 2 
quiescent    and for the number of quiescent cells dead     when no concentration 3 
approaches a threshold. Rates were determined by their most restrictive factor    4 
                ,                    ,                     and corrected 5 
for the amount of available space according Table  4. 6 
Limiting factor Condition Transition Parameter Values 
Oxygen Below optimum, but above 
proliferation threshold 
               
           
 
 
 
       
          
 
 
 
            
 
 
 
       
           
   
      
Oxygen Below proliferation, but 
above survival threshold 
            
            
      
Oxygen Below survival threshold 
         
        
   
  
   
 
 
      
       
   
  
   
 
 
Glucose Below optimum, but above 
proliferation threshold 
               
            
 
 
 
       
          
 
 
 
           
 
 
 
       
          
 
 
 
      
Glucose Below proliferation, but 
above survival threshold 
            
       
         
      
Glucose Below survival threshold 
         
        
   
  
   
 
 
      
       
   
  
   
 
 
Waste Below optimum, but above 
proliferation threshold 
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Waste Below proliferation, but 
above survival threshold 
            
        
        
      
Waste Below survival threshold 
         
        
  
   
   
 
 
      
       
  
   
   
 
 
 1 
Table 4: Correction of transition rates in dependence on available space Transition rates 2 
of Equation 4 and Table 3 were corrected for the amount of cell density (cd). Free space was 3 
assumed whenever the total concentration of cells was below           
             , 4 
while full space was assumed was assumed whenever the total cell density exceeded     5 
                     . 6 
             
             
           
 
 
 
      
     
 
 
 
             
       
           
      
     
 
 
 
 7 
Table 5: Boundary conditions for nutrient distributions: Homogenous boundary 8 
conditions were assumed to mimic optimum oxygen and glucose supply as well as maximum 9 
waste disposal for the AVE at the vessel location (           i.e. at the vessel surface). 10 
Migration of cells between the vessel and the tumour were disregarded. Likewise, no flow of 11 
cells and nutrients waste was assumed. However, source term correction for cells and 12 
nutrients was considered as described in the text. 13 
Boundary condition at vessel 
Boundary condition at 
surface 
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 1 
  Highlights  
 
1. We provide a numerically fast method to calculate the evolution of proliferating, dead and 
quiescent cells, and hence a proliferative index, of a vascularised tumour from a given amount 
and distribution of tumour vascularisation of arbitrary complexity. 
2. We were able to demonstrate that a heterogeneous vascularisation promotes a higher amount of 
cellular turnover (higher replacement of dead cells) than a homogenous one, suggesting a higher 
tumour agressiveness.    
3. We further demonstrate that increased tumour cell proliferation is possible under certain 
conditions, even when the amount of vascularisation decreases. This effect was due to a trade-off 
between an increase in compensatory proliferation for replacing dead cells and a decrease of cell 
population due to lack of oxygen supply in lowly vascularised tumours. 
4. We illustrated above model prediction by de novo data from mouse tumour xenografts,  
5. In conclusio, we here devised the first method to study vascular tumour formation by reducing it 
to a study of avascular tumour growth, and demonstrate its applicability in translational systems 
biology  
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